≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Hypertrichosis

DOID Endpoint Browser

L12_HYPERTRICHOSIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L68
  • Cause of death: ICD-10 — L68

2 out of 7 registries used, show all original rules.

883

4. Check minimum number of events

None

883

5. Include endpoints

941

6. Filter based on genotype QC (FinnGen only)

860

Control definitions (FinnGen only)

Control exclude
L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L60-L75
Name in latin
Hypertrichosis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 860 849 11
Unadjusted period prevalence (%) 0.30 0.30 0.01
Median age at first event (years) 33.78 33.74 36.14

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
941
Matched controls
9410
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L68.0
ICD-10 Finland
Hirsutism
4596.1
307.7
804
12
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
19.6
271.6
230
153
C03DA01
ATC
spironolactone; oral
13.7
258.6
279
281
G03HB01
ATC
cyproterone and estrogen; oral
4.8
115.0
366
1094
A10BA02
ATC
metformin; oral
4.8
109.9
350
1042
L68.9
ICD-10 Finland
Hypertrichosis, unspecified
+∞
93.3
88
*
E66.01
ICD-10 Finland
Obesity due to excess calories
3.9
68.2
252
805
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.5
49.1
199
664
E66.8
ICD-10 Finland
Other obesity
4.1
47.4
147
408
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
5.3
46.5
99
203
L68.2
ICD-10 Finland
Localized hypertrichosis
447.5
43.6
43
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
43.4
222
849
T90
ICPC
Diabetes non-insulin dependent
3.2
41.9
202
745
A10BJ06
ATC
semaglutide; parenteral
5.2
41.8
91
190
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.1
41.7
217
837
G03DB01
ATC
dydrogesterone; oral
2.8
40.0
264
1155
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
5.1
39.8
89
190
E66.00
ICD-10 Finland
Metabolic syndrome
4.7
36.8
90
207
T82
ICPC
Obesity
4.1
36.3
106
280
E66.9
ICD-10 Finland
Obesity, unspecified
4.4
34.7
93
230
70405
ICD-8 Finland
Diseases of hair and hair follicles, Hypertrichosis
+∞
34.6
33
*
7041A
ICD-9 Finland
Diseases of hair and hair follicles, Hirsutism[HIRSUTISMUS]
+∞
32.5
31
*
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
10.7
31.7
35
34
A10BK03
ATC
empagliflozin; oral
3.9
31.5
98
270
L68.8
ICD-10 Finland
Other hypertrichosis
106.8
28.8
31
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.1
28.2
507
3331
G03HA01
ATC
cyproterone; systemic
77.5
26.9
30
*
N05AH04
ATC
quetiapine; oral
2.3
25.4
249
1278
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
25.0
170
739
A10BH01
ATC
sitagliptin; oral
3.8
24.8
78
216
N05AX12
ATC
aripiprazole; systemic
3.4
24.7
97
312
L73.2
ICD-10 Finland
Hidradenitis suppurativa
20.1
23.6
35
18
A10BB12
ATC
glimepiride; oral
6.3
22.5
38
62
L70.0
ICD-10 Finland
Acne vulgaris
4.1
22.5
64
165
S10
ICPC
Boil/carbuncle
3.4
22.4
83
257
N97.0
ICD-10 Finland
Female infertility associated with anovulation
3.8
22.0
71
200
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
21.6
216
1110
G47.3
ICD-10 Finland
Sleep apnoea
2.3
21.0
194
964
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
20.9
97
344
N06AB04
ATC
citalopram; systemic
2.1
19.9
230
1247
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.2
19.7
211
1110
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.7
19.6
63
177
N06AX12
ATC
bupropion; oral
2.4
19.5
144
647
N06AX16
ATC
venlafaxine; oral
2.2
19.5
208
1093
E66
ICD-10 Finland
Obesity
2.8
19.4
107
417
A10BJ02
ATC
liraglutide; parenteral
4.4
19.0
48
113
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.7
18.7
109
437
LCA06
NOMESCO Finland
Biopsy of endometrium
2.2
18.5
178
896
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
18.1
116
487
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.5
18.1
65
197
M79.6
ICD-10 Finland
Pain in limb
1.8
17.7
459
3233
N03AX09
ATC
lamotrigine; oral
2.7
17.4
97
379
H03AA01
ATC
levothyroxine sodium; systemic
1.9
16.8
266
1601
N06AB03
ATC
fluoxetine; oral
2.2
16.7
151
738
C07AB07
ATC
bisoprolol; oral
1.9
16.5
297
1860
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
4.1
16.1
44
110
R42
ICD-10 Finland
Dizziness and giddiness
2.0
16.1
207
1158
N06AX11
ATC
mirtazapine; oral
1.8
15.9
353
2353
N05AX08
ATC
risperidone; systemic
2.8
15.9
84
319
N05BA04
ATC
oxazepam; oral
1.9
15.6
277
1722
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
15.5
333
2197
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
15.0
149
755
N06AB10
ATC
escitalopram; oral
1.8
14.9
291
1860
N03AG01
ATC
valproic acid; systemic, rectal
2.8
14.9
80
307
L17
ICPC
Foot/toe symptom/complaint
1.8
14.5
311
2040
N05AH03
ATC
olanzapine; systemic
2.6
14.5
92
383
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.2
14.5
140
701
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
6.1
14.4
25
42
H01
ICPC
Ear pain/earache
2.0
14.3
186
1040
M54.5
ICD-10 Finland
Low back pain
1.7
14.3
401
2837
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.1
14.2
62
212
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
14.2
156
822
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
14.1
96
414
A10AE04
ATC
insulin glargine; parenteral
2.7
14.0
79
311
N06AX21
ATC
duloxetine; oral
2.1
14.0
151
790
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.7
431
3136
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
13.6
160
863
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
13.4
89
379
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
13.3
148
781
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
13.3
83
343
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
12.9
102
470
SPAT1262
SPAT
Handing over of treatment supplies
2.2
12.8
123
614
A11
ICPC
Chest pain NOS
2.7
12.8
70
271
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
9.8
12.8
25
26
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
12.7
158
868
P76
ICPC
Depressive disorder
2.1
12.6
125
632
L68
ICD-10 Finland
Hypertrichosis
+∞
12.5
12
*
L03
ICPC
Low back symptom/complaint
1.7
12.5
335
2320
E66.0
ICD-10 Finland
Obesity due to excess calories
13.4
12.5
21
16
F61.0
ICD-10 Finland
Mixed personality disorders
4.0
12.4
35
90
QBJ30
NOMESCO Finland
Correction of abdominal apron
5.4
12.3
24
45
N06AB06
ATC
sertraline; oral
1.9
12.2
167
946
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
12.2
50
165
P06
ICPC
Sleep disturbance
1.9
12.2
170
971
S18
ICPC
Laceration/cut
1.7
12.2
381
2744
OAB72, ,
SPAT
3.8
12.0
37
101
205
Kela drug reimbursment
Chronic hypertension
2.3
12.0
99
464
J01FF01
ATC
clindamycin; systemic
1.8
12.0
237
1506
N05CF01
ATC
zopiclone; oral
1.7
12.0
250
1614
A10BK01
ATC
dapagliflozin; oral
2.9
11.9
57
205
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
11.9
64
245
C07AA05
ATC
propranolol; systemic
1.7
11.9
248
1599
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
11.8
144
785
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.1
11.8
49
163
N05AA02
ATC
levomepromazine; systemic
3.3
11.6
43
133
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
11.5
217
1359
N03AX16
ATC
[U] pregabalin
1.8
11.4
185
1106
N02AX02
ATC
tramadol; systemic, rectal
1.7
11.4
326
2284
N03AX12
ATC
[U] gabapentin; oral
2.0
11.4
139
757
A02BC02
ATC
pantoprazole; systemic
1.6
11.4
575
4630
A28
ICPC
Limited function/disability NOS
2.3
11.3
90
415
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.4
11.3
40
120
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.6
11.3
66
264
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.1
206
1282
SPAT1310
SPAT
Counselling related to known health issue
1.6
11.1
322
2262
R51.80
ICD-10 Finland
Headache
1.8
11.0
217
1373
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.4
10.9
40
123
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
10.9
56
210
SPAT1240
SPAT
Therapeutic discussion
1.8
10.8
169
999
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.9
10.7
144
810
A01
ICPC
Pain general/multiple sites
2.1
10.6
106
536
A10BD07
ATC
metformin and sitagliptin; systemic
4.2
10.5
28
69
N03AX11
ATC
topiramate; oral
2.9
10.5
48
169
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
5.5
10.4
20
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
10.4
215
1377
G44.2
ICD-10 Finland
Tension-type headache
1.8
10.4
184
1129
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
10.3
52
193
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.3
281
1937
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
10.2
75
334
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.0
10.2
117
622
R4190
NOMESCO Finland
Nutritional therapy
2.8
10.2
52
194
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
10.2
193
1206
P99
ICPC
Psychological disorders other
2.7
10.2
55
212
A10BJ05
ATC
dulaglutide; parenteral
4.4
10.1
25
58
R06.0
ICD-10 Finland
Dyspnoea
1.7
10.1
216
1397
N03AE01
ATC
clonazepam; systemic
2.7
10.0
52
196
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
10.0
237
3366
ACC51
NOMESCO Finland
Release of median nerve
2.3
10.0
81
377
P03
ICPC
Feeling depressed
1.8
10.0
181
1117
P29
ICPC
Psychological sympt/compl other
1.9
9.9
136
769
P01
ICPC
Feeling anxious/nervous/tense
1.7
9.9
247
1661
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
9.9
108
564
C09CA01
ATC
losartan; oral
1.9
9.9
140
801
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.1
9.7
26
64
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
3.9
9.7
28
73
N91.5
ICD-10 Finland
Oligomenorrhoea, unspecified
5.4
9.7
19
36
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.7
348
2557
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
9.6
54
212
L73.8
ICD-10 Finland
Other specified follicular disorders
11.5
9.6
17
15
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
9.6
61
255
D01
ICPC
Abdominal pain/cramps general
1.8
9.5
168
1029
L72.1
ICD-10 Finland
Trichilemmal cyst
2.6
9.5
54
214
Z3231
NOMESCO Finland
Registered nurse
1.7
9.4
227
1512
R13
ICD-10 Finland
Dysphagia
2.5
9.4
60
251
C03CA01
ATC
furosemide; systemic
2.0
9.4
111
597
E0000UV, ,
ATC
1.5
9.3
414
3181
XLA10, ,
NOMESCO Finland
2.4
9.3
61
259
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.1
9.2
96
493
R06.5
ICD-10 Finland
Mouth breathing
2.3
9.0
72
333
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.9
9.0
115
635
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
8.9
178
1125
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
8.9
89
450
A29
ICPC
General symptom/complaint other
1.9
8.9
115
637
L28
ICPC
Limited function/disability (L)
1.9
8.9
123
697
L73.9
ICD-10 Finland
Follicular disorder, unspecified
12.7
8.9
15
12
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
8.9
188
1208
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.7
8.9
20
43
C10AA05
ATC
atorvastatin; oral
1.7
8.8
193
1250
G03DC02
ATC
norethisterone; oral
2.0
8.8
96
501
ZYC01, ,
SPAT
1.8
8.8
143
852
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
8.7
119
671
J02AC01
ATC
fluconazole; systemic
1.5
8.6
471
3763
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
8.6
192
1252
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.5
217
1461
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
6.5
8.5
21
33
E28.1
ICD-10 Finland
Ovarian dysfunction: Androgen excess
27.8
8.5
11
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
8.5
97
516
S76
ICPC
Skin infection other
2.6
8.4
50
202
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
8.4
74
356
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
8.4
194
1273
N02BE01
ATC
paracetamol; systemic, rectal
1.8
8.4
822
7459
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
8.3
189
1236
F40.1
ICD-10 Finland
Social phobias
2.6
8.3
49
198
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
8.3
79
393
M25.5
ICD-10 Finland
Pain in joint
1.5
8.2
345
2599
P01AB01
ATC
metronidazole; oral, rectal
1.5
8.2
404
3147
G03GB02
ATC
clomifene; oral
3.0
8.2
36
124
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.6
8.2
251
3408
N02BF02
ATC
pregabalin; oral
2.2
8.2
72
347
A04
ICPC
Weakness/tiredness general
1.7
8.1
184
1201
R4110, ,
SPAT
1.9
8.1
110
619
M79.1
ICD-10 Finland
Myalgia
1.7
8.1
184
1202
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
3.8
8.1
24
64
L86
ICPC
Back syndrome with radiating pain
2.3
8.1
62
282
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
8.1
195
1294
S29
ICPC
Skin symptom/complaint other
1.6
8.1
190
1253
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
8.1
220
1505
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.0
401
3128
C09AA02
ATC
enalapril; systemic
2.0
8.0
86
447
A10AB05
ATC
insulin aspart; parenteral
2.3
8.0
59
264
J01DB01
ATC
cefalexin; oral
1.7
8.0
784
7043
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
8.0
58
258
N05BA01
ATC
diazepam; systemic, rectal
1.9
8.0
103
571
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
7.9
284
2065
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
7.9
541
4488
OAB50, ,
SPAT
2.3
7.9
60
272
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.8
7.8
23
61
TQW80
NOMESCO Finland
Local dermatologic skincare
4.1
7.8
21
52
J01AA02
ATC
doxycycline; systemic
1.5
7.8
661
5721
OAB42, ,
SPAT
1.7
7.8
151
946
E28.0
ICD-10 Finland
Ovarian dysfunction: Estrogen excess
45.4
7.7
9
*
U04
ICPC
Incontinence urine
2.6
7.7
44
175
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
7.7
337
2556
L15
ICPC
Knee symptom/complaint
1.6
7.7
229
1598
SPAT1260
SPAT
Consultation of another employee
1.7
7.6
154
974
D06
ICPC
Abdominal pain localized other
1.8
7.6
116
677
N06AA09
ATC
amitriptyline; systemic
2.1
7.6
71
350
E27.0
ICD-10 Finland
Other adrenocortical overactivity
18.5
7.6
11
6
IHZ05, ,
SPAT
2.0
7.6
83
434
F61
ICD-10 Finland
Mixed and other personality disorders
12.0
7.6
13
11
M04AA01
ATC
allopurinol; systemic
2.7
7.5
41
159
T07
ICPC
Weight gain
2.9
7.5
35
125
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.2
7.5
64
305
A10BH05
ATC
linagliptin; oral
3.6
7.5
24
68
F32
ICD-10 Finland
Depressive episode
2.0
7.4
79
409
L64.8
ICD-10 Finland
Other androgenic alopecia
80.7
7.4
8
*
P72
ICPC
Schizophrenia
3.5
7.3
24
69
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.5
7.3
83
1460
SPAT1216
SPAT
Assessment of functional ability
1.9
7.3
89
484
T83
ICPC
Overweight
2.6
7.3
42
168
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.2
292
2171
D10BA01
ATC
isotretinoin; oral
1.9
7.2
93
515
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
7.2
166
1087
S06
ICPC
Rash localized
2.3
7.2
51
225
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
7.1
126
768
A46
ICD-10 Finland
Erysipelas
2.0
7.1
76
394
W78
ICPC
Pregnancy
0.6
7.1
176
2526
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.1
473
3873
N17
ICPC
Vertigo/dizziness
1.8
7.0
113
670
L18
ICPC
Muscle pain
2.4
7.0
48
208
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.5
7.0
306
2309
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.6
7.0
41
165
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
7.0
49
215
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.9
72
370
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
6.9
49
216
N05CD07
ATC
temazepam; oral
2.2
6.9
55
255
N04AA02
ATC
biperiden; systemic
3.5
6.9
23
67
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
6.9
37
143
L29.9
ICD-10 Finland
Pruritus, unspecified
2.7
6.9
37
143
H60
ICD-10 Finland
Otitis externa
2.1
6.8
65
323
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
6.8
112
668
SPAT1254
SPAT
Administration of medicine
1.7
6.8
131
817
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.8
200
1386
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.8
92
517
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.8
432
3496
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
6.2
6.8
17
28
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.7
6.8
21
58
M79.7
ICD-10 Finland
Fibromyalgia
2.3
6.8
51
231
A01AB09
ATC
miconazole; local oral
2.0
6.7
69
353
M10.9
ICD-10 Finland
Gout, unspecified
3.3
6.7
24
73
A08
ICPC
Swelling
2.4
6.7
44
187
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
6.7
126
781
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.7
128
798
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.7
178
1207
N06AB05
ATC
paroxetine; oral
2.1
6.7
62
306
-34
ICPC
Blood test
2.8
6.6
32
117
ZY010
NOMESCO Finland
Hospital outpatient
2.0
6.6
72
377
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
6.6
30
106
L60.0
ICD-10 Finland
Ingrowing nail
2.4
6.6
44
189
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
6.6
143
922
B01AA03
ATC
warfarin; systemic
2.2
6.6
56
267
R03AC02
ATC
salbutamol; inhalant
1.4
6.6
543
4598
K03.66
ICD-10 Finland
Tooth plaque
2.0
6.5
71
371
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.2
6.5
25
80
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.5
6.5
74
1303
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.3
6.5
24
75
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
6.4
354
2782
QDH01
NOMESCO Finland
Excision of nail bed in toe
70.3
6.4
7
*
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.9
6.4
29
102
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.4
719
6430
N05AF03
ATC
chlorprothixene; systemic
2.8
6.4
30
108
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
6.3
39
161
SPAT1283
SPAT
Restricted health certificate
1.5
6.3
275
2066
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
6.3
142
922
C09CA06
ATC
candesartan; oral
1.6
6.3
186
1289
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
6.3
32
120
S21
ICPC
Skin texture symptom/complaint
1.7
6.3
133
851
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.6
6.3
146
2134
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
6.2
75
406
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.7
6.2
19
52
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.2
312
2408
Z2445
NOMESCO Finland
Psychologist
2.2
6.2
53
253
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
6.2
157
1051
H92.0
ICD-10 Finland
Otalgia
1.8
6.2
85
481
SPAT1301
SPAT
No procedures
1.5
6.1
261
1951
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
3.8
6.1
18
48
A10AE05
ATC
insulin detemir; parenteral
2.4
6.1
42
183
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.1
158
1064
SGA01
NOMESCO Finland
Emergency treatment
1.5
6.1
188
1317
DHB50
NOMESCO Finland
Turbinoplasty
2.7
6.0
31
117
N06AX26
ATC
vortioxetine; oral
1.7
6.0
102
614
SPAT1263
SPAT
Sampling
1.4
6.0
390
3146
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.3
6.0
22
68
Z2446
NOMESCO Finland
Social worker
2.0
6.0
64
332
A02BC03
ATC
lansoprazole; oral
1.5
6.0
188
1319
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.5
6.0
35
141
N05AB03
ATC
perphenazine; systemic, rectal
2.5
6.0
35
141

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
spironolactone; oral
C03DA01 [21601534]
1.9e+00
2.5e+00
1.9e+00
—
4.3e+00
4.2e+00
3.7e+00
cases:3.01%
controls:0.45%
cases:3.90%
controls:0.33%
cases:0.78%
controls:0.12%
—
—
cases:5.68%
controls:0.08%
cases:14.83%
controls:0.26%
cases:15.45%
controls:0.43%
27
40
871
8932
35
30
863
8942
7
11
891
8961
—
51
7
847
8954
128
23
735
8675
119
33
651
7611
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14688-6 [3016616]
2.7e+00
4.8e+00
1.0e+50
1.0e+50
1.0e+50
4.5e+00
3.2e+00
cases:2.34%
controls:0.17%
cases:7.80%
controls:0.07%
cases:7.24%
controls:0.00%
cases:0.89%
controls:0.00%
cases:6.46%
controls:0.00%
cases:5.91%
controls:0.07%
cases:4.16%
controls:0.18%
21
15
877
8957
70
6
828
8966
65
0
833
8972
8
0
890
8972
58
0
840
8961
51
6
812
8692
32
14
738
7630
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
3.0e+00
5.0e+00
—
1.0e+50
—
4.1e+00
2.8e+00
cases:5.90%
controls:0.32%
cases:16.04%
controls:0.12%
—
—
cases:0.89%
controls:0.00%
—
—
cases:6.49%
controls:0.11%
cases:6.49%
controls:0.42%
53
29
845
8943
144
11
754
8961
—
8
0
890
8972
—
56
10
807
8688
50
32
720
7612
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
8.5e-01
2.2e+00
4.3e+00
—
3.9e+00
2.2e+00
1.3e+00
cases:3.56%
controls:1.56%
cases:5.90%
controls:0.67%
cases:4.01%
controls:0.06%
—
—
cases:3.23%
controls:0.07%
cases:4.63%
controls:0.53%
cases:5.06%
controls:1.48%
32
140
866
8832
53
60
845
8912
36
5
862
8967
—
29
6
869
8955
40
46
823
8652
39
113
731
7531
Polycystic ovarian syndrome
E28.2 [45533028]
2.1e+00
3.7e+00
—
1.0e+50
—
4.2e+00
3.1e+00
cases:3.56%
controls:0.43%
cases:4.12%
controls:0.11%
—
—
cases:9.80%
controls:0.00%
—
—
cases:10.08%
controls:0.17%
cases:11.17%
controls:0.59%
32
39
866
8933
37
10
861
8962
—
88
0
810
8972
—
87
15
776
8683
86
45
684
7599
Obstetrics / Gynecology
16 [38004461]
2.1e-02
1.3e-01
1.6e-01
7.3e+00
1.9e+00
1.8e+00
4.7e-01
cases:34.63%
controls:34.16%
cases:15.81%
controls:14.10%
cases:3.12%
controls:2.66%
cases:65.48%
controls:0.13%
cases:15.03%
controls:2.51%
cases:49.71%
controls:13.49%
cases:44.03%
controls:32.95%
311
3065
587
5907
142
1265
756
7707
28
239
870
8733
588
12
310
8960
135
225
763
8736
429
1173
434
7525
339
2519
431
5125
Outpatient Visit
OP [9202]
3.4e-01
4.9e-01
6.1e-01
6.1e+00
1.3e+00
1.3e+00
7.7e-01
cases:73.39%
controls:66.22%
cases:54.68%
controls:42.53%
cases:16.15%
controls:9.45%
cases:66.93%
controls:0.43%
cases:27.39%
controls:9.23%
cases:72.19%
controls:41.57%
cases:83.90%
controls:70.70%
659
5941
239
3031
491
3816
407
5156
145
848
753
8124
601
39
297
8933
246
827
652
8134
623
3616
240
5082
646
5404
124
2240
cyproterone and estrogen
G03HB01 [21602617]
9.3e-01
1.1e+00
7.0e-01
—
3.5e+00
2.8e+00
2.3e+00
cases:8.91%
controls:3.70%
cases:4.57%
controls:1.56%
cases:0.78%
controls:0.39%
—
—
cases:7.02%
controls:0.23%
cases:17.61%
controls:1.30%
cases:19.61%
controls:2.42%
80
332
818
8640
41
140
857
8832
7
35
891
8937
—
63
21
835
8940
152
113
711
8585
151
185
619
7459
Obesity due to excess calories
E66.01 [2000501501]
1.0e+00
1.5e+00
2.1e+00
1.0e+50
2.2e+00
1.9e+00
1.6e+00
cases:3.67%
controls:1.33%
cases:3.45%
controls:0.79%
cases:0.89%
controls:0.11%
cases:3.34%
controls:0.00%
cases:1.22%
controls:0.13%
cases:5.68%
controls:0.89%
cases:8.83%
controls:1.95%
33
119
865
8853
31
71
867
8901
8
10
890
8962
30
0
868
8972
11
12
887
8949
49
77
814
8621
68
149
702
7495
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
1.8e+00
2.4e+00
—
—
—
3.4e+00
2.5e+00
cases:1.56%
controls:0.26%
cases:0.89%
controls:0.08%
—
—
—
—
—
—
cases:1.97%
controls:0.07%
cases:1.69%
controls:0.14%
14
23
884
8949
8
7
890
8965
—
—
—
17
6
846
8692
13
11
757
7633
Insulin [Units/volume] in Serum or Plasma
20448-7 [3016244]
1.7e+00
2.6e+00
—
—
—
3.4e+00
2.2e+00
cases:0.89%
controls:0.16%
cases:1.34%
controls:0.10%
—
—
—
—
—
—
cases:1.97%
controls:0.07%
cases:1.69%
controls:0.18%
8
14
890
8958
12
9
886
8963
—
—
—
17
6
846
8692
13
14
757
7630
metformin; oral
A10BA02 [21600747]
1.3e+00
1.3e+00
1.5e+00
—
2.2e+00
2.0e+00
1.7e+00
cases:8.91%
controls:2.61%
cases:6.79%
controls:1.93%
cases:2.12%
controls:0.48%
—
—
cases:4.34%
controls:0.52%
cases:12.28%
controls:1.91%
cases:16.49%
controls:3.55%
80
234
818
8738
61
173
837
8799
19
43
879
8929
—
39
47
859
8914
106
166
757
8532
127
271
643
7373
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
2.4e+00
—
—
1.0e+50
—
4.5e+00
2.8e+00
cases:1.89%
controls:0.18%
—
—
—
—
cases:0.78%
controls:0.00%
—
—
cases:5.10%
controls:0.06%
cases:3.25%
controls:0.20%
17
16
881
8956
—
—
7
0
891
8972
—
44
5
819
8693
25
15
745
7629
Macroprolactin [Units/volume] in Serum or Plasma
74953-1 [44816844]
1.9e+00
3.2e+00
—
—
—
2.4e+00
2.0e+00
cases:3.34%
controls:0.50%
cases:4.34%
controls:0.18%
—
—
—
—
—
—
cases:1.51%
controls:0.14%
cases:3.38%
controls:0.47%
30
45
868
8927
39
16
859
8956
—
—
—
13
12
850
8686
26
36
744
7608
Metabolic syndrome
E66.00 [2000501500]
1.7e+00
2.6e+00
—
1.0e+50
—
3.0e+00
2.1e+00
cases:1.56%
controls:0.29%
cases:0.89%
controls:0.07%
—
—
cases:1.00%
controls:0.00%
—
—
cases:1.62%
controls:0.08%
cases:3.12%
controls:0.39%
14
26
884
8946
8
6
890
8966
—
9
0
889
8972
—
14
7
849
8691
24
30
746
7614
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
1.4e+00
3.3e+00
—
—
—
2.7e+00
1.7e+00
cases:3.79%
controls:0.99%
cases:7.24%
controls:0.30%
—
—
—
—
—
—
cases:3.94%
controls:0.26%
cases:4.94%
controls:0.90%
34
89
864
8883
65
27
833
8945
—
—
—
34
23
829
8675
38
69
732
7575
Follitropin [Units/volume] in Serum or Plasma by Immunoassay
83098-4 [42529215]
1.7e+00
2.7e+00
—
—
—
2.7e+00
1.6e+00
cases:2.34%
controls:0.42%
cases:2.45%
controls:0.17%
—
—
—
—
—
—
cases:1.51%
controls:0.10%
cases:2.47%
controls:0.48%
21
38
877
8934
22
15
876
8957
—
—
—
13
9
850
8689
19
37
751
7607
Psychiatry
26 [38004469]
9.9e-01
1.3e+00
1.2e+00
1.6e+00
1.2e+00
1.3e+00
1.0e+00
cases:19.82%
controls:8.39%
cases:13.81%
controls:4.29%
cases:6.35%
controls:1.96%
cases:0.89%
controls:0.18%
cases:6.12%
controls:1.98%
cases:15.06%
controls:4.66%
cases:22.08%
controls:9.20%
178
753
720
8219
124
385
774
8587
57
176
841
8796
8
16
890
8956
55
177
843
8784
130
405
733
8293
170
703
600
6941
Pharmacy visit
OMOP4822462 [581458]
5.5e-01
7.7e-01
4.9e-01
2.6e+00
9.7e-01
1.5e+00
1.4e+00
cases:95.21%
controls:91.96%
cases:88.08%
controls:77.35%
cases:43.88%
controls:32.28%
cases:15.48%
controls:1.40%
cases:55.57%
controls:32.12%
cases:94.09%
controls:78.21%
cases:98.70%
controls:94.69%
855
8251
43
721
791
6940
107
2032
394
2896
504
6076
139
126
759
8846
499
2878
399
6083
812
6803
51
1895
760
7238
10
406
clozapine; oral, parenteral
N05AH02 [21604542]
1.5e+00
1.6e+00
1.6e+00
—
1.6e+00
1.8e+00
1.7e+00
cases:1.34%
controls:0.30%
cases:1.22%
controls:0.25%
cases:0.89%
controls:0.19%
—
—
cases:1.00%
controls:0.20%
cases:1.51%
controls:0.26%
cases:1.95%
controls:0.38%
12
27
886
8945
11
22
887
8950
8
17
890
8955
—
9
18
889
8943
13
23
850
8675
15
29
755
7615
Mixed personality disorders
F61.0 [2000502024]
1.9e+00
2.2e+00
—
—
—
2.1e+00
1.7e+00
cases:1.45%
controls:0.21%
cases:1.11%
controls:0.12%
—
—
—
—
—
—
cases:1.27%
controls:0.16%
cases:1.43%
controls:0.26%
13
19
885
8953
10
11
888
8961
—
—
—
11
14
852
8684
11
20
759
7624
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
4.6e-01
8.3e-01
1.3e+00
—
2.1e+00
1.8e+00
1.2e+00
cases:9.47%
controls:6.20%
cases:5.35%
controls:2.40%
cases:1.45%
controls:0.39%
—
—
cases:3.01%
controls:0.38%
cases:12.75%
controls:2.43%
cases:17.27%
controls:6.14%
85
556
813
8416
48
215
850
8757
13
35
885
8937
—
27
34
871
8927
110
211
753
8487
133
469
637
7175
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
1.4e+00
2.5e+00
—
—
1.0e+50
3.0e+00
2.1e+00
cases:0.56%
controls:0.14%
cases:0.67%
controls:0.06%
—
—
—
—
cases:0.67%
controls:0.00%
cases:1.85%
controls:0.09%
cases:1.17%
controls:0.14%
5
13
893
8959
6
5
892
8967
—
—
6
0
892
8961
16
8
847
8690
9
11
761
7633
Obesity, unspecified
E66.9 [45576460]
1.7e+00
1.8e+00
—
1.0e+50
—
2.3e+00
1.6e+00
cases:1.89%
controls:0.33%
cases:1.00%
controls:0.17%
—
—
cases:1.34%
controls:0.00%
—
—
cases:1.85%
controls:0.18%
cases:2.21%
controls:0.43%
17
30
881
8942
9
15
889
8957
—
12
0
886
8972
—
16
16
847
8682
17
33
753
7611
dydrogesterone; oral
G03DB01 [21602544]
9.2e-01
1.7e+00
1.4e+00
—
2.2e+00
1.5e+00
1.1e+00
cases:9.13%
controls:3.87%
cases:6.24%
controls:1.19%
cases:1.00%
controls:0.26%
—
—
cases:2.12%
controls:0.23%
cases:5.91%
controls:1.39%
cases:8.96%
controls:3.14%
82
347
816
8625
56
107
842
8865
9
23
889
8949
—
19
21
879
8940
51
121
812
8577
69
240
701
7404
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.6e-01
7.1e-01
1.0e+00
2.7e+00
1.2e+00
8.7e-01
5.6e-01
cases:27.84%
controls:21.13%
cases:22.94%
controls:12.74%
cases:5.79%
controls:2.22%
cases:1.00%
controls:0.07%
cases:5.68%
controls:1.82%
cases:25.72%
controls:12.72%
cases:39.48%
controls:27.16%
250
1896
648
7076
206
1143
692
7829
52
199
846
8773
9
6
889
8966
51
163
847
8798
222
1106
641
7592
304
2076
466
5568
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.8e-01
7.3e-01
1.0e+00
2.7e+00
1.1e+00
8.6e-01
5.5e-01
cases:27.95%
controls:20.90%
cases:22.94%
controls:12.58%
cases:5.79%
controls:2.22%
cases:1.00%
controls:0.07%
cases:5.46%
controls:1.80%
cases:25.61%
controls:12.74%
cases:39.09%
controls:27.09%
251
1875
647
7097
206
1129
692
7843
52
199
846
8773
9
6
889
8966
49
161
849
8800
221
1108
642
7590
301
2071
469
5573
lamotrigine; oral
N03AX09 [21604431]
9.8e-01
1.6e+00
1.3e+00
—
1.7e+00
1.5e+00
1.4e+00
cases:3.01%
controls:1.15%
cases:2.78%
controls:0.58%
cases:0.67%
controls:0.18%
—
—
cases:0.89%
controls:0.16%
cases:2.55%
controls:0.56%
cases:4.29%
controls:1.06%
27
103
871
8869
25
52
873
8920
6
16
892
8956
—
8
14
890
8947
22
49
841
8649
33
81
737
7563
Diabetes non-insulin dependent
T90 [2002001131]
1.1e+00
1.2e+00
2.3e+00
—
1.3e+00
1.3e+00
1.3e+00
cases:3.79%
controls:1.25%
cases:2.56%
controls:0.81%
cases:0.78%
controls:0.08%
—
—
cases:0.78%
controls:0.21%
cases:2.90%
controls:0.82%
cases:5.97%
controls:1.66%
34
112
864
8860
23
73
875
8899
7
7
891
8965
—
7
19
891
8942
25
71
838
8627
46
127
724
7517
Estradiol (E2) [Moles/volume] in Serum or Plasma
14715-7 [3026725]
1.1e+00
2.4e+00
1.0e+50
—
1.0e+50
2.1e+00
1.3e+00
cases:2.12%
controls:0.71%
cases:2.67%
controls:0.25%
cases:1.78%
controls:0.00%
—
—
cases:0.78%
controls:0.00%
cases:1.16%
controls:0.15%
cases:2.60%
controls:0.75%
19
64
879
8908
24
22
874
8950
16
0
882
8972
—
7
0
891
8961
10
13
853
8685
20
57
750
7587
citalopram; oral, parenteral
N06AB04 [21604712]
1.1e+00
1.1e+00
1.3e+00
—
1.3e+00
9.9e-01
1.0e+00
cases:8.57%
controls:3.17%
cases:4.68%
controls:1.59%
cases:1.56%
controls:0.42%
—
—
cases:1.56%
controls:0.45%
cases:4.17%
controls:1.60%
cases:8.96%
controls:3.34%
77
284
821
8688
42
143
856
8829
14
38
884
8934
—
14
40
884
8921
36
139
827
8559
69
255
701
7389
Other obesity
E66.8 [45533036]
1.5e+00
1.3e+00
—
1.0e+50
1.7e+00
2.1e+00
1.9e+00
cases:2.78%
controls:0.66%
cases:1.34%
controls:0.38%
—
—
cases:1.00%
controls:0.00%
cases:0.56%
controls:0.10%
cases:3.01%
controls:0.37%
cases:5.06%
controls:0.82%
25
59
873
8913
12
34
886
8938
—
9
0
889
8972
5
9
893
8952
26
32
837
8666
39
63
731
7581
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
9.0e-01
2.8e+00
—
—
—
1.9e+00
1.1e+00
cases:4.12%
controls:1.72%
cases:9.02%
controls:0.60%
—
—
—
—
—
—
cases:3.36%
controls:0.51%
cases:5.32%
controls:1.88%
37
154
861
8818
81
54
817
8918
—
—
—
29
44
834
8654
41
144
729
7500
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
2.3e+00
2.6e+00
—
—
—
—
1.7e+00
cases:0.89%
controls:0.09%
cases:0.89%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.18%
8
8
890
8964
8
6
890
8966
—
—
—
—
8
14
762
7630
Type 2 diabetes mellitus
E11 [45571656]
1.3e+00
2.1e+00
—
—
—
1.7e+00
1.4e+00
cases:3.67%
controls:1.01%
cases:2.45%
controls:0.30%
—
—
—
—
—
—
cases:1.85%
controls:0.34%
cases:5.58%
controls:1.41%
33
91
865
8881
22
27
876
8945
—
—
—
16
30
847
8668
43
108
727
7536
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
2.0e+00
1.8e+00
—
—
—
2.8e+00
1.7e+00
cases:0.78%
controls:0.11%
cases:0.56%
controls:0.09%
—
—
—
—
—
—
cases:1.51%
controls:0.09%
cases:1.17%
controls:0.22%
7
10
891
8962
5
8
893
8964
—
—
—
13
8
850
8690
9
17
761
7627
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.0e+00
1.8e+00
2.0e+00
—
1.7e+00
1.7e+00
1.7e+00
cases:1.89%
controls:0.68%
cases:2.12%
controls:0.36%
cases:0.56%
controls:0.08%
—
—
cases:0.67%
controls:0.12%
cases:1.51%
controls:0.29%
cases:2.73%
controls:0.50%
17
61
881
8911
19
32
879
8940
5
7
893
8965
—
6
11
892
8950
13
25
850
8673
21
38
749
7606
Headache
R51.80 [2000503603]
6.6e-01
1.0e+00
—
—
2.5e+00
1.4e+00
6.2e-01
cases:4.90%
controls:2.59%
cases:1.67%
controls:0.61%
—
—
—
—
cases:0.67%
controls:0.06%
cases:2.43%
controls:0.63%
cases:5.19%
controls:2.85%
44
232
854
8740
15
55
883
8917
—
—
6
5
892
8956
21
55
842
8643
40
218
730
7426
Acne vulgaris
L70.0 [45581958]
1.4e+00
2.5e+00
—
1.0e+50
—
2.2e+00
1.2e+00
cases:1.45%
controls:0.36%
cases:1.22%
controls:0.10%
—
—
cases:0.89%
controls:0.00%
—
—
cases:1.62%
controls:0.18%
cases:1.17%
controls:0.35%
13
32
885
8940
11
9
887
8963
—
8
0
890
8972
—
14
16
849
8682
9
27
761
7617
Neurology
13 [38004458]
7.8e-01
8.6e-01
1.1e+00
—
1.5e+00
1.1e+00
8.0e-01
cases:13.92%
controls:6.91%
cases:7.46%
controls:3.31%
cases:2.34%
controls:0.77%
—
—
cases:2.67%
controls:0.64%
cases:8.81%
controls:3.25%
cases:15.19%
controls:7.46%
125
620
773
8352
67
297
831
8675
21
69
877
8903
—
24
57
874
8904
76
283
787
8415
117
570
653
7074
Unspecified nonorganic psychosis
F29 [45533099]
8.7e-01
1.7e+00
2.1e+00
—
2.3e+00
2.0e+00
1.0e+00
cases:1.56%
controls:0.66%
cases:1.56%
controls:0.28%
cases:0.56%
controls:0.07%
—
—
cases:0.67%
controls:0.07%
cases:1.51%
controls:0.21%
cases:1.17%
controls:0.43%
14
59
884
8913
14
25
884
8947
5
6
893
8966
—
6
6
892
8955
13
18
850
8680
9
33
761
7611
sitagliptin; oral
A10BH01 [21600784]
1.5e+00
1.6e+00
—
—
—
1.6e+00
1.3e+00
cases:1.45%
controls:0.33%
cases:1.00%
controls:0.21%
—
—
—
—
—
—
cases:0.93%
controls:0.18%
cases:1.56%
controls:0.42%
13
30
885
8942
9
19
889
8953
—
—
—
8
16
855
8682
12
32
758
7612
drospirenone
G03AC10 [1588689]
7.3e-01
1.1e+00
8.7e-01
—
2.3e+00
1.6e+00
8.6e-01
cases:1.34%
controls:0.65%
cases:2.23%
controls:0.76%
cases:0.56%
controls:0.23%
—
—
cases:1.89%
controls:0.20%
cases:4.29%
controls:0.86%
cases:5.45%
controls:2.39%
12
58
886
8914
20
68
878
8904
5
21
893
8951
—
17
18
881
8943
37
75
826
8623
42
183
728
7461
Poisoning by systemic antibiotics
T36 [45756588]
8.6e-01
2.0e+00
—
—
—
2.6e+00
1.3e+00
cases:1.34%
controls:0.57%
cases:0.78%
controls:0.11%
—
—
—
—
—
—
cases:1.04%
controls:0.08%
cases:1.69%
controls:0.48%
12
51
886
8921
7
10
891
8962
—
—
—
9
7
854
8691
13
37
757
7607
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.9e-01
5.7e-01
8.4e-01
2.0e+00
9.8e-01
6.9e-01
3.7e-01
cases:30.07%
controls:24.40%
cases:25.39%
controls:16.17%
cases:7.02%
controls:3.15%
cases:0.78%
controls:0.11%
cases:6.68%
controls:2.62%
cases:28.27%
controls:16.52%
cases:40.78%
controls:32.21%
270
2189
628
6783
228
1451
670
7521
63
283
835
8689
7
10
891
8962
60
235
838
8726
244
1437
619
7261
314
2462
456
5182
Follitropin [Units/volume] in Serum or Plasma
15067-2 [3023323]
7.2e-01
2.4e+00
—
—
—
1.7e+00
8.4e-01
cases:3.23%
controls:1.59%
cases:6.57%
controls:0.66%
—
—
—
—
—
—
cases:3.13%
controls:0.60%
cases:4.68%
controls:2.07%
29
143
869
8829
59
59
839
8913
—
—
—
27
52
836
8646
36
158
734
7486
oxazepam; oral
N05BA04 [21604569]
8.3e-01
1.1e+00
9.5e-01
—
1.5e+00
1.2e+00
9.0e-01
cases:10.02%
controls:4.64%
cases:6.01%
controls:2.13%
cases:1.22%
controls:0.48%
—
—
cases:1.67%
controls:0.37%
cases:7.18%
controls:2.18%
cases:12.08%
controls:5.29%
90
416
808
8556
54
191
844
8781
11
43
887
8929
—
15
33
883
8928
62
190
801
8508
93
404
677
7240
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
3.7e-01
9.9e-01
1.5e+00
—
1.4e+00
6.7e-01
5.8e-01
cases:24.28%
controls:18.12%
cases:19.71%
controls:8.34%
cases:4.45%
controls:1.03%
—
—
cases:2.90%
controls:0.75%
cases:15.64%
controls:8.65%
cases:34.03%
controls:22.33%
218
1626
680
7346
177
748
721
8224
40
92
858
8880
—
26
67
872
8894
135
752
728
7946
262
1707
508
5937
Dysthymia
F34.1 [45586238]
1.2e+00
2.1e+00
—
—
—
2.1e+00
3.5e-01
cases:1.78%
controls:0.55%
cases:0.89%
controls:0.11%
—
—
—
—
—
—
cases:1.04%
controls:0.13%
cases:0.91%
controls:0.64%
16
49
882
8923
8
10
890
8962
—
—
—
9
11
854
8687
7
49
763
7595
Lutropin/Follitropin [Ratio] in Serum or Plasma
34434-1 [3045209]
2.8e+00
—
1.0e+50
—
1.0e+50
—
2.5e+00
cases:0.89%
controls:0.06%
—
—
cases:1.00%
controls:0.00%
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.91%
controls:0.08%
8
5
890
8967
—
9
0
889
8972
—
5
0
893
8961
—
7
6
763
7638
Sleep apnoea
G47.3 [45562094]
1.3e+00
1.3e+00
—
—
8.2e-01
1.4e+00
1.3e+00
cases:3.90%
controls:1.13%
cases:3.01%
controls:0.87%
—
—
—
—
cases:0.56%
controls:0.25%
cases:3.13%
controls:0.79%
cases:6.75%
controls:1.92%
35
101
863
8871
27
78
871
8894
—
—
5
22
893
8939
27
69
836
8629
52
147
718
7497
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.2e-01
9.3e-01
1.7e+00
—
1.2e+00
4.4e-01
4.8e-01
cases:30.07%
controls:22.05%
cases:27.17%
controls:12.80%
cases:8.24%
controls:1.67%
—
—
cases:5.12%
controls:1.56%
cases:19.35%
controls:13.35%
cases:40.13%
controls:29.30%
270
1978
628
6994
244
1148
654
7824
74
150
824
8822
—
46
140
852
8821
167
1161
696
7537
309
2240
461
5404
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
4.5e-01
9.0e-01
1.4e+00
—
1.0e+00
7.6e-01
5.3e-01
cases:18.82%
controls:12.85%
cases:17.82%
controls:8.09%
cases:4.45%
controls:1.14%
—
—
cases:2.67%
controls:0.96%
cases:15.99%
controls:8.21%
cases:32.21%
controls:21.79%
169
1153
729
7819
160
726
738
8246
40
102
858
8870
—
24
86
874
8875
138
714
725
7984
248
1666
522
5978
Essential (primary) hypertension
I10 [45591453]
7.8e-01
9.2e-01
9.2e-01
—
1.4e+00
1.1e+00
9.1e-01
cases:7.24%
controls:3.47%
cases:4.45%
controls:1.83%
cases:0.67%
controls:0.27%
—
—
cases:1.34%
controls:0.35%
cases:4.98%
controls:1.76%
cases:10.52%
controls:4.51%
65
311
833
8661
40
164
858
8808
6
24
892
8948
—
12
31
886
8930
43
153
820
8545
81
345
689
7299
Laboratory Visit
OMOP4822461 [32036]
6.3e-02
2.9e-01
9.1e-01
2.5e+00
9.3e-01
2.8e-01
3.3e-02
cases:39.64%
controls:38.14%
cases:40.98%
controls:34.08%
cases:22.16%
controls:10.32%
cases:5.46%
controls:0.46%
cases:20.94%
controls:9.49%
cases:41.25%
controls:34.73%
cases:49.09%
controls:48.26%
356
3422
542
5550
368
3058
530
5914
199
926
699
8046
49
41
849
8931
188
850
710
8111
356
3021
507
5677
378
3689
392
3955
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.9e-01
9.2e-01
1.6e+00
—
9.0e-01
4.6e-01
5.0e-01
cases:27.39%
controls:18.77%
cases:21.38%
controls:9.82%
cases:6.01%
controls:1.23%
—
—
cases:3.01%
controls:1.25%
cases:14.95%
controls:9.98%
cases:34.42%
controls:24.19%
246
1684
652
7288
192
881
706
8091
54
110
844
8862
—
27
112
871
8849
129
868
734
7830
265
1849
505
5795
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
4.8e-01
8.5e-01
2.3e+00
—
—
1.7e+00
8.2e-01
cases:2.56%
controls:1.60%
cases:1.11%
controls:0.48%
cases:0.67%
controls:0.07%
—
—
—
—
cases:1.97%
controls:0.37%
cases:2.99%
controls:1.33%
23
144
875
8828
10
43
888
8929
6
6
892
8966
—
—
17
32
846
8666
23
102
747
7542
Secondary amenorrhoea
N91.1 [45601758]
8.4e-01
2.1e+00
—
1.0e+50
—
2.7e+00
1.3e+00
cases:1.00%
controls:0.43%
cases:1.22%
controls:0.14%
—
—
cases:2.23%
controls:0.00%
—
—
cases:1.62%
controls:0.11%
cases:0.91%
controls:0.26%
9
39
889
8933
11
13
887
8959
—
20
0
878
8972
—
14
10
849
8688
7
20
763
7624
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.2e+00
1.1e+00
1.3e+00
—
—
1.3e+00
1.2e+00
cases:3.23%
controls:0.98%
cases:1.89%
controls:0.64%
cases:1.22%
controls:0.35%
—
—
—
—
cases:2.67%
controls:0.77%
cases:3.90%
controls:1.19%
29
88
869
8884
17
57
881
8915
11
31
887
8941
—
—
23
67
840
8631
30
91
740
7553
olanzapine; oral, parenteral
N05AH03 [21604543]
9.9e-01
1.2e+00
9.2e-01
—
1.5e+00
1.3e+00
1.2e+00
cases:3.23%
controls:1.23%
cases:2.23%
controls:0.68%
cases:0.56%
controls:0.22%
—
—
cases:1.00%
controls:0.23%
cases:2.78%
controls:0.76%
cases:3.64%
controls:1.13%
29
110
869
8862
20
61
878
8911
5
20
893
8952
—
9
21
889
8940
24
66
839
8632
28
86
742
7558
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
1.3e+00
2.1e+00
—
—
—
1.7e+00
1.3e+00
cases:1.78%
controls:0.51%
cases:0.78%
controls:0.10%
—
—
—
—
—
—
cases:0.58%
controls:0.10%
cases:1.82%
controls:0.50%
16
46
882
8926
7
9
891
8963
—
—
—
5
9
858
8689
14
38
756
7606
Biopsy of endometrium
LCA06 [2001306551]
8.9e-01
1.2e+00
—
1.0e+50
—
1.5e+00
9.8e-01
cases:2.90%
controls:1.20%
cases:1.34%
controls:0.39%
—
—
cases:2.12%
controls:0.00%
—
—
cases:1.27%
controls:0.29%
cases:3.51%
controls:1.35%
26
108
872
8864
12
35
886
8937
—
19
0
879
8972
—
11
25
852
8673
27
103
743
7541
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
1.0e+00
1.1e+00
2.0e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:3.90%
controls:1.44%
cases:2.45%
controls:0.80%
cases:0.56%
controls:0.08%
—
—
cases:0.56%
controls:0.08%
cases:1.97%
controls:0.56%
cases:4.16%
controls:1.48%
35
129
863
8843
22
72
876
8900
5
7
893
8965
—
5
7
893
8954
17
49
846
8649
32
113
738
7531
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
1.3e+00
1.6e+00
1.8e+00
—
—
2.2e+00
2.2e+00
cases:0.67%
controls:0.19%
cases:0.56%
controls:0.11%
cases:0.56%
controls:0.09%
—
—
—
—
cases:0.93%
controls:0.10%
cases:1.82%
controls:0.21%
6
17
892
8955
5
10
893
8962
5
8
893
8964
—
—
8
9
855
8689
14
16
756
7628
Boil/carbuncle
S10 [2002000975]
1.3e+00
1.6e+00
—
—
—
1.8e+00
1.5e+00
cases:1.34%
controls:0.38%
cases:1.00%
controls:0.20%
—
—
—
—
—
—
cases:0.70%
controls:0.11%
cases:2.21%
controls:0.51%
12
34
886
8938
9
18
889
8954
—
—
—
6
10
857
8688
17
39
753
7605
Obesity due to excess calories
E66.0 [45581372]
—
—
—
—
—
2.3e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:0.91%
controls:0.12%
—
—
—
—
—
6
6
857
8692
7
9
763
7635
Supplier / Service Provider
OMOP5117446 [33004]
-8.4e-01
-1.2e+00
—
—
—
3.0e+00
3.4e+00
cases:15.92%
controls:30.56%
cases:2.78%
controls:8.99%
—
—
—
—
—
—
cases:4.75%
controls:0.24%
cases:12.34%
controls:0.46%
143
2742
755
6230
25
807
873
8165
—
—
—
41
21
822
8677
95
35
675
7609
Prolactin monomeric [Units/volume] in Serum or Plasma
78994-1 [21491979]
—
2.5e+00
1.0e+50
—
1.0e+50
—
1.9e+00
—
—
cases:0.78%
controls:0.07%
cases:1.00%
controls:0.00%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.04%
controls:0.16%
—
7
6
891
8966
9
0
889
8972
—
5
0
893
8961
—
8
12
762
7632
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
1.1e+00
1.2e+00
-1.0e+50
—
—
1.2e+00
8.4e-01
cases:3.12%
controls:1.04%
cases:1.45%
controls:0.46%
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.62%
controls:0.48%
cases:3.38%
controls:1.49%
28
93
870
8879
13
41
885
8931
0
9
898
8963
—
—
14
42
849
8656
26
114
744
7530
Case Management Agency
251B00000X [38004193]
1.2e-01
2.5e-01
3.3e-01
3.3e+00
4.3e-01
2.0e-01
1.5e-01
cases:57.80%
controls:54.75%
cases:55.35%
controls:49.13%
cases:27.84%
controls:21.70%
cases:30.29%
controls:1.55%
cases:29.96%
controls:21.77%
cases:55.74%
controls:50.82%
cases:67.40%
controls:63.95%
519
4912
379
4060
497
4408
401
4564
250
1947
648
7025
272
139
626
8833
269
1951
629
7010
481
4420
382
4278
519
4888
251
2756
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.7e-01
7.7e-01
1.2e+00
—
1.7e+00
7.1e-01
6.9e-01
cases:8.02%
controls:5.18%
cases:4.45%
controls:2.11%
cases:1.00%
controls:0.31%
—
—
cases:0.89%
controls:0.17%
cases:4.17%
controls:2.10%
cases:10.52%
controls:5.59%
72
465
826
8507
40
189
858
8783
9
28
889
8944
—
8
15
890
8946
36
183
827
8515
81
427
689
7217
bupropion; oral
N06AX12 [21604741]
7.3e-01
1.4e+00
1.1e+00
—
1.5e+00
1.3e+00
9.1e-01
cases:3.01%
controls:1.47%
cases:2.67%
controls:0.70%
cases:0.67%
controls:0.22%
—
—
cases:0.89%
controls:0.20%
cases:3.01%
controls:0.84%
cases:4.42%
controls:1.83%
27
132
871
8840
24
63
874
8909
6
20
892
8952
—
8
18
890
8943
26
73
837
8625
34
140
736
7504
Prolactin monomeric/Prolactin.total in Serum or Plasma
50366-4 [3031309]
—
2.5e+00
1.0e+50
—
1.0e+50
—
1.8e+00
—
—
cases:0.78%
controls:0.07%
cases:1.00%
controls:0.00%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.04%
controls:0.17%
—
7
6
891
8966
9
0
889
8972
—
5
0
893
8961
—
8
13
762
7631
Myalgia
M79.1 [45587062]
7.7e-01
1.1e+00
—
—
—
1.3e+00
1.1e+00
cases:3.79%
controls:1.78%
cases:1.67%
controls:0.58%
—
—
—
—
—
—
cases:1.85%
controls:0.51%
cases:5.06%
controls:1.73%
34
160
864
8812
15
52
883
8920
—
—
—
16
44
847
8654
39
132
731
7512
Upper gastrointestinal surgery
106 [44777669]
4.2e-01
7.3e-01
—
—
1.7e+00
1.0e+00
7.6e-01
cases:7.80%
controls:5.27%
cases:3.56%
controls:1.75%
—
—
—
—
cases:1.34%
controls:0.25%
cases:4.52%
controls:1.66%
cases:10.52%
controls:5.19%
70
473
828
8499
32
157
866
8815
—
—
12
22
886
8939
39
144
824
8554
81
397
689
7247
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.1e+00
8.6e-01
—
—
—
1.6e+00
1.5e+00
cases:3.79%
controls:1.25%
cases:1.67%
controls:0.71%
—
—
—
—
—
—
cases:3.94%
controls:0.84%
cases:7.01%
controls:1.66%
34
112
864
8860
15
64
883
8908
—
—
—
34
73
829
8625
54
127
716
7517
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
7.7e-01
1.3e+00
—
—
1.3e+00
1.0e+00
1.1e+00
cases:3.01%
controls:1.42%
cases:2.34%
controls:0.65%
—
—
—
—
cases:0.67%
controls:0.19%
cases:2.09%
controls:0.76%
cases:5.06%
controls:1.79%
27
127
871
8845
21
58
877
8914
—
—
6
17
892
8944
18
66
845
8632
39
137
731
7507
combinations of corticosteroids
D07AB30 [21602118]
4.7e-01
7.2e-01
1.1e+00
—
1.5e+00
8.8e-01
5.9e-01
cases:12.92%
controls:8.49%
cases:6.12%
controls:3.08%
cases:1.11%
controls:0.38%
—
—
cases:1.45%
controls:0.32%
cases:5.79%
controls:2.49%
cases:15.45%
controls:9.18%
116
762
782
8210
55
276
843
8696
10
34
888
8938
—
13
29
885
8932
50
217
813
8481
119
702
651
6942
combinations of corticosteroids
D07XB30 [21602188]
4.7e-01
7.2e-01
1.1e+00
—
1.5e+00
8.8e-01
5.9e-01
cases:12.92%
controls:8.49%
cases:6.12%
controls:3.08%
cases:1.11%
controls:0.38%
—
—
cases:1.45%
controls:0.32%
cases:5.79%
controls:2.49%
cases:15.45%
controls:9.18%
116
762
782
8210
55
276
843
8696
10
34
888
8938
—
13
29
885
8932
50
217
813
8481
119
702
651
6942
bisoprolol; oral
C07AB07 [21601689]
6.4e-01
7.0e-01
7.1e-01
—
1.0e+00
8.0e-01
9.6e-01
cases:7.57%
controls:4.16%
cases:6.01%
controls:3.07%
cases:1.78%
controls:0.88%
—
—
cases:2.00%
controls:0.73%
cases:6.84%
controls:3.18%
cases:12.47%
controls:5.17%
68
373
830
8599
54
275
844
8697
16
79
882
8893
—
18
65
880
8896
59
277
804
8421
96
395
674
7249
Telephone prescription or other care instructions
WZB00 [2001310884]
3.1e-01
2.5e-01
—
—
2.9e+00
1.2e+00
3.1e-01
cases:7.57%
controls:5.68%
cases:2.34%
controls:1.83%
—
—
—
—
cases:1.45%
controls:0.08%
cases:4.87%
controls:1.54%
cases:6.49%
controls:4.87%
68
510
830
8462
21
164
877
8808
—
—
13
7
885
8954
42
134
821
8564
50
372
720
7272
Endocrinology
46 [38004485]
4.5e-01
6.4e-01
6.4e-01
—
1.5e+00
1.4e+00
5.8e-01
cases:6.01%
controls:3.92%
cases:5.23%
controls:2.84%
cases:1.22%
controls:0.65%
—
—
cases:2.56%
controls:0.57%
cases:10.43%
controls:2.86%
cases:9.48%
controls:5.53%
54
352
844
8620
47
255
851
8717
11
58
887
8914
—
23
51
875
8910
90
249
773
8449
73
423
697
7221
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.3e+00
1.4e+00
—
—
1.2e+00
1.4e+00
8.8e-01
cases:3.23%
controls:0.86%
cases:2.12%
controls:0.52%
—
—
—
—
cases:0.67%
controls:0.21%
cases:1.97%
controls:0.52%
cases:1.69%
controls:0.71%
29
77
869
8895
19
47
879
8925
—
—
6
19
892
8942
17
45
846
8653
13
54
757
7590
Office Visit
OMOP4822458 [581477]
4.7e-01
4.1e-01
1.5e-01
—
1.9e+00
1.0e+00
7.2e-01
cases:11.47%
controls:7.47%
cases:3.45%
controls:2.32%
cases:0.56%
controls:0.48%
—
—
cases:1.89%
controls:0.30%
cases:5.56%
controls:2.07%
cases:11.17%
controls:5.78%
103
670
795
8302
31
208
867
8764
5
43
893
8929
—
17
27
881
8934
48
180
815
8518
86
442
684
7202
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
2.0e+00
—
—
—
—
—
2.1e+00
cases:1.56%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.24%
14
20
884
8952
—
—
—
—
—
14
18
756
7626
Otolaryngology
4 [38004449]
4.9e-01
7.5e-01
7.0e-01
—
1.2e+00
8.9e-01
6.7e-01
cases:13.25%
controls:8.55%
cases:5.79%
controls:2.81%
cases:0.89%
controls:0.45%
—
—
cases:1.45%
controls:0.44%
cases:6.03%
controls:2.58%
cases:14.03%
controls:7.73%
119
767
779
8205
52
252
846
8720
8
40
890
8932
—
13
39
885
8922
52
224
811
8474
108
591
662
7053
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.2e-01
7.4e-01
1.5e+00
—
2.6e+00
5.2e-01
3.9e-01
cases:7.46%
controls:4.15%
cases:3.23%
controls:1.56%
cases:0.67%
controls:0.16%
—
—
cases:0.89%
controls:0.07%
cases:2.78%
controls:1.67%
cases:7.40%
controls:5.13%
67
372
831
8600
29
140
869
8832
6
14
892
8958
—
8
6
890
8955
24
145
839
8553
57
392
713
7252
quetiapine; oral
N05AH04 [21604544]
9.2e-01
9.2e-01
7.5e-01
—
9.2e-01
1.0e+00
1.0e+00
cases:9.02%
controls:3.81%
cases:5.23%
controls:2.16%
cases:1.34%
controls:0.64%
—
—
cases:1.34%
controls:0.54%
cases:6.14%
controls:2.26%
cases:10.39%
controls:4.04%
81
342
817
8630
47
194
851
8778
12
57
886
8915
—
12
48
886
8913
53
197
810
8501
80
309
690
7335
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
47845-3 [3048821]
1.3e+00
3.8e+00
1.0e+50
—
1.0e+50
—
—
cases:0.78%
controls:0.21%
cases:3.01%
controls:0.07%
cases:1.34%
controls:0.00%
—
—
cases:1.22%
controls:0.00%
—
—
—
—
7
19
891
8953
27
6
871
8966
12
0
886
8972
—
11
0
887
8961
—
—
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
4.7e-01
1.3e+00
—
—
—
1.5e+00
9.7e-01
cases:2.90%
controls:1.83%
cases:1.67%
controls:0.45%
—
—
—
—
—
—
cases:1.27%
controls:0.29%
cases:3.25%
controls:1.26%
26
164
872
8808
15
40
883
8932
—
—
—
11
25
852
8673
25
96
745
7548
clindamycin; vaginal
G01AA10 [21602372]
3.2e-01
9.4e-01
—
—
2.3e+00
6.3e-01
5.0e-01
cases:6.90%
controls:5.13%
cases:3.90%
controls:1.56%
—
—
—
—
cases:1.00%
controls:0.10%
cases:2.78%
controls:1.49%
cases:7.53%
controls:4.70%
62
460
836
8512
35
140
863
8832
—
—
9
9
889
8952
24
130
839
8568
58
359
712
7285
INR in Blood by Coagulation assay
34714-6 [3032080]
5.2e-01
7.5e-01
7.4e-01
—
1.4e+00
1.0e+00
4.5e-01
cases:6.57%
controls:4.02%
cases:3.34%
controls:1.60%
cases:0.56%
controls:0.27%
—
—
cases:1.11%
controls:0.27%
cases:3.82%
controls:1.45%
cases:7.27%
controls:4.77%
59
361
839
8611
30
144
868
8828
5
24
893
8948
—
10
24
888
8937
33
126
830
8572
56
365
714
7279
mirtazapine; oral
N06AX11 [21604740]
6.9e-01
5.7e-01
1.6e+00
—
7.2e-01
6.7e-01
6.8e-01
cases:8.80%
controls:4.64%
cases:4.23%
controls:2.44%
cases:1.89%
controls:0.39%
—
—
cases:1.00%
controls:0.49%
cases:4.40%
controls:2.31%
cases:11.43%
controls:6.14%
79
416
819
8556
38
219
860
8753
17
35
881
8937
—
9
44
889
8917
38
201
825
8497
88
469
682
7175
Feeling anxious/nervous/tense
P01 [2002000798]
6.1e-01
9.1e-01
1.2e+00
—
1.4e+00
6.8e-01
3.7e-01
cases:7.02%
controls:3.96%
cases:3.79%
controls:1.56%
cases:1.11%
controls:0.33%
—
—
cases:1.34%
controls:0.32%
cases:3.59%
controls:1.85%
cases:6.88%
controls:4.85%
63
355
835
8617
34
140
864
8832
10
30
888
8942
—
12
29
886
8932
31
161
832
8537
53
371
717
7273
Insertion of intrauterine device
TLC00 [2001306647]
1.0e+00
1.0e+00
—
1.0e+50
—
1.8e+00
8.1e-01
cases:3.01%
controls:1.08%
cases:1.00%
controls:0.37%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.39%
controls:0.24%
cases:2.86%
controls:1.30%
27
97
871
8875
9
33
889
8939
—
5
0
893
8972
—
12
21
851
8677
22
99
748
7545
other preparations, combinations; ointment
C05AX03 [21601631]
6.8e-01
8.6e-01
2.2e+00
—
—
3.5e-01
7.4e-01
cases:3.67%
controls:1.89%
cases:1.67%
controls:0.71%
cases:0.67%
controls:0.08%
—
—
—
—
cases:0.93%
controls:0.66%
cases:4.03%
controls:1.96%
33
170
865
8802
15
64
883
8908
6
7
892
8965
—
—
8
57
855
8641
31
150
739
7494
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.4e-01
7.9e-01
1.1e+00
—
1.7e+00
5.5e-01
6.7e-01
cases:8.57%
controls:5.68%
cases:5.46%
controls:2.56%
cases:1.11%
controls:0.37%
—
—
cases:1.00%
controls:0.19%
cases:4.29%
controls:2.53%
cases:12.73%
controls:6.97%
77
510
821
8462
49
230
849
8742
10
33
888
8939
—
9
17
889
8944
37
220
826
8478
98
533
672
7111
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.1e+00
8.5e-01
1.1e+00
—
1.1e+00
1.3e+00
1.2e+00
cases:3.12%
controls:1.09%
cases:1.11%
controls:0.48%
cases:0.56%
controls:0.18%
—
—
cases:0.56%
controls:0.19%
cases:1.51%
controls:0.40%
cases:3.51%
controls:1.13%
28
98
870
8874
10
43
888
8929
5
16
893
8956
—
5
17
893
8944
13
35
850
8663
27
86
743
7558
Tension-type headache
G44.2 [45581495]
6.8e-01
9.7e-01
-1.0e+50
—
—
1.2e+00
7.1e-01
cases:3.67%
controls:1.89%
cases:1.78%
controls:0.68%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.85%
controls:0.57%
cases:4.03%
controls:2.03%
33
170
865
8802
16
61
882
8911
0
7
898
8965
—
—
16
50
847
8648
31
155
739
7489
EKG study
11524-6 [3013512]
8.6e-01
8.2e-01
1.1e+00
—
—
1.1e+00
6.9e-01
cases:5.79%
controls:2.53%
cases:2.56%
controls:1.15%
cases:0.56%
controls:0.18%
—
—
—
—
cases:3.24%
controls:1.12%
cases:6.88%
controls:3.56%
52
227
846
8745
23
103
875
8869
5
16
893
8956
—
—
28
97
835
8601
53
272
717
7372
Persons encountering health services in other specified circumstances
Z76.8 [45542457]
—
—
—
—
—
2.2e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.08%
cases:1.69%
controls:0.48%
—
—
—
—
—
6
7
857
8691
13
37
757
7607
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.3e-01
5.8e-01
1.3e+00
—
9.5e-01
6.0e-01
5.3e-01
cases:9.13%
controls:6.13%
cases:5.23%
controls:3.01%
cases:1.34%
controls:0.38%
—
—
cases:0.89%
controls:0.35%
cases:6.26%
controls:3.53%
cases:14.81%
controls:9.31%
82
550
816
8422
47
270
851
8702
12
34
886
8938
—
8
31
890
8930
54
307
809
8391
114
712
656
6932
pregabalin; oral
N02BF02 [955152]
7.4e-01
9.0e-01
7.5e-01
—
6.2e-01
8.9e-01
8.0e-01
cases:3.90%
controls:1.89%
cases:2.45%
controls:1.01%
cases:0.89%
controls:0.42%
—
—
cases:0.89%
controls:0.48%
cases:2.67%
controls:1.12%
cases:5.19%
controls:2.39%
35
170
863
8802
22
91
876
8881
8
38
890
8934
—
8
43
890
8918
23
97
840
8601
40
183
730
7461
agomelatine; oral
N06AX22 [21604750]
7.7e-01
1.7e+00
—
—
—
1.8e+00
1.5e+00
cases:1.00%
controls:0.47%
cases:0.67%
controls:0.12%
—
—
—
—
—
—
cases:1.04%
controls:0.17%
cases:1.17%
controls:0.26%
9
42
889
8930
6
11
892
8961
—
—
—
9
15
854
8683
9
20
761
7624
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
5.2e-01
6.4e-01
7.0e-01
—
5.1e-01
6.9e-01
6.8e-01
cases:11.36%
controls:7.07%
cases:12.36%
controls:6.90%
cases:3.67%
controls:1.85%
—
—
cases:3.23%
controls:1.96%
cases:13.09%
controls:7.02%
cases:16.49%
controls:9.11%
102
634
796
8338
111
619
787
8353
33
166
865
8806
—
29
176
869
8785
113
611
750
8087
127
696
643
6948
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
3.0e-01
7.0e-01
9.0e-01
—
1.0e+00
3.5e-01
3.1e-01
cases:21.71%
controls:17.08%
cases:16.82%
controls:9.11%
cases:2.67%
controls:1.10%
—
—
cases:2.67%
controls:1.00%
cases:12.86%
controls:9.39%
cases:31.82%
controls:25.54%
195
1532
703
7440
151
817
747
8155
24
99
874
8873
—
24
90
874
8871
111
817
752
7881
245
1952
525
5692
amitriptyline; oral, parenteral
N06AA09 [21604696]
7.4e-01
7.5e-01
1.1e+00
—
4.5e-01
1.1e+00
6.2e-01
cases:6.90%
controls:3.42%
cases:3.01%
controls:1.45%
cases:0.78%
controls:0.27%
—
—
cases:0.56%
controls:0.36%
cases:4.29%
controls:1.47%
cases:7.14%
controls:3.99%
62
307
836
8665
27
130
871
8842
7
24
891
8948
—
5
32
893
8929
37
128
826
8570
55
305
715
7339
Internal Medicine
11 [38004456]
3.2e-01
4.0e-01
5.6e-01
1.0e+50
1.4e+00
9.7e-01
5.4e-01
cases:18.37%
controls:14.09%
cases:8.57%
controls:5.92%
cases:1.89%
controls:1.09%
cases:5.68%
controls:0.00%
cases:3.67%
controls:0.97%
cases:13.09%
controls:5.43%
cases:22.08%
controls:14.22%
165
1264
733
7708
77
531
821
8441
17
98
881
8874
51
0
847
8972
33
87
865
8874
113
472
750
8226
170
1087
600
6557
zopiclone; oral
N05CF01 [21604654]
6.2e-01
1.0e+00
9.9e-01
—
7.9e-01
8.2e-01
7.0e-01
cases:7.24%
controls:4.01%
cases:4.34%
controls:1.59%
cases:0.89%
controls:0.33%
—
—
cases:1.00%
controls:0.46%
cases:4.06%
controls:1.83%
cases:8.05%
controls:4.16%
65
360
833
8612
39
143
859
8829
8
30
890
8942
—
9
41
889
8920
35
159
828
8539
62
318
708
7326
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.9e-01
4.9e-01
7.1e-01
—
9.0e-01
4.8e-01
3.1e-01
cases:29.62%
controls:23.95%
cases:22.72%
controls:15.31%
cases:5.35%
controls:2.70%
—
—
cases:5.12%
controls:2.15%
cases:23.06%
controls:15.68%
cases:39.22%
controls:32.03%
266
2149
632
6823
204
1374
694
7598
48
242
850
8730
—
46
193
852
8768
199
1364
664
7334
302
2448
468
5196
Physical Medicine And Rehabilitation
25 [38004468]
5.7e-01
8.2e-01
4.5e-01
—
5.7e-01
1.1e+00
6.8e-01
cases:7.24%
controls:4.24%
cases:3.45%
controls:1.55%
cases:0.56%
controls:0.36%
—
—
cases:0.67%
controls:0.38%
cases:4.87%
controls:1.67%
cases:10.00%
controls:5.32%
65
380
833
8592
31
139
867
8833
5
32
893
8940
—
6
34
892
8927
42
145
821
8553
77
407
693
7237
Obesity
T82 [2002001125]
1.5e+00
1.4e+00
—
—
—
1.5e+00
1.7e+00
cases:2.00%
controls:0.46%
cases:0.56%
controls:0.13%
—
—
—
—
—
—
cases:0.93%
controls:0.22%
cases:2.99%
controls:0.58%
18
41
880
8931
5
12
893
8960
—
—
—
8
19
855
8679
23
44
747
7600
Severe psychotic and other severe mental disorders
112 [2001600112]
1.2e+00
1.9e+00
—
—
—
1.9e+00
1.4e+00
cases:2.23%
controls:0.67%
cases:1.00%
controls:0.14%
—
—
—
—
—
—
cases:0.70%
controls:0.10%
cases:1.17%
controls:0.30%
20
60
878
8912
9
13
889
8959
—
—
—
6
9
857
8689
9
23
761
7621
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
8.6e-01
9.1e-01
—
—
—
1.2e+00
1.1e+00
cases:2.67%
controls:1.15%
cases:1.56%
controls:0.64%
—
—
—
—
—
—
cases:1.97%
controls:0.59%
cases:3.64%
controls:1.28%
24
103
874
8869
14
57
884
8915
—
—
—
17
51
846
8647
28
98
742
7546
Fibromyalgia
M79.7 [45553272]
8.9e-01
—
—
—
—
1.5e+00
1.6e+00
cases:0.89%
controls:0.37%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.23%
cases:1.43%
controls:0.29%
8
33
890
8939
—
—
—
—
9
20
854
8678
11
22
759
7622
trazodone; oral
N06AX05 [21604734]
1.3e+00
1.9e+00
—
—
—
—
—
cases:1.34%
controls:0.38%
cases:0.78%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
12
34
886
8938
7
11
891
8961
—
—
—
—
—
venlafaxine; oral
N06AX16 [21604745]
6.9e-01
7.0e-01
2.7e-01
—
9.6e-01
7.5e-01
9.8e-01
cases:5.23%
controls:2.71%
cases:3.45%
controls:1.75%
cases:0.67%
controls:0.51%
—
—
cases:1.45%
controls:0.56%
cases:3.36%
controls:1.62%
cases:7.53%
controls:2.97%
47
243
851
8729
31
157
867
8815
6
46
892
8926
—
13
50
885
8911
29
141
834
8557
58
227
712
7417
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
—
—
1.0e+50
—
1.0e+50
—
3.1e+00
—
—
—
—
cases:3.01%
controls:0.00%
—
—
cases:2.23%
controls:0.00%
—
—
cases:1.69%
controls:0.08%
—
—
27
0
871
8972
—
20
0
878
8961
—
13
6
757
7638
Dietary counselling and surveillance
Z71.3 [45552101]
5.9e-01
1.5e+00
—
—
—
1.8e+00
1.3e+00
cases:1.00%
controls:0.56%
cases:0.67%
controls:0.14%
—
—
—
—
—
—
cases:0.93%
controls:0.16%
cases:2.08%
controls:0.56%
9
50
889
8922
6
13
892
8959
—
—
—
8
14
855
8684
16
43
754
7601
chlorhexidine
S03AA04 [21605193]
6.0e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.86%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
167
868
8805
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
chlorhexidine, combinations
D08AC52 [21602208]
6.0e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.86%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
167
868
8805
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
6.0e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.86%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
167
868
8805
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
chlorhexidine
D09AA12 [21602275]
6.0e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.86%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
167
868
8805
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
hydrocortisone and antiseptics
D07BA04 [21602146]
5.9e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.87%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
168
868
8804
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
hydrocortisone
D07XA01 [21602180]
5.9e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.87%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
168
868
8804
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
chlorhexidine
S02AA09 [21605155]
6.0e-01
1.0e+00
—
—
—
1.1e+00
9.0e-01
cases:3.34%
controls:1.86%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.48%
cases:4.16%
controls:1.74%
30
167
868
8805
16
58
882
8914
—
—
—
13
42
850
8656
32
133
738
7511
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
7.9e-01
9.1e-01
—
—
—
1.1e+00
1.2e+00
cases:4.12%
controls:1.91%
cases:1.78%
controls:0.72%
—
—
—
—
—
—
cases:2.20%
controls:0.75%
cases:5.32%
controls:1.71%
37
171
861
8801
16
65
882
8907
—
—
—
19
65
844
8633
41
131
729
7513
macrogol; oral
A06AD15 [21600575]
1.0e+00
—
—
—
—
1.6e+00
1.5e+00
cases:1.22%
controls:0.45%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.22%
cases:2.86%
controls:0.68%
11
40
887
8932
—
—
—
—
9
19
854
8679
22
52
748
7592
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
7.7e-01
7.3e-01
9.6e-01
—
6.5e-01
8.2e-01
7.1e-01
cases:9.58%
controls:4.67%
cases:3.56%
controls:1.75%
cases:0.78%
controls:0.30%
—
—
cases:0.56%
controls:0.29%
cases:3.71%
controls:1.67%
cases:9.61%
controls:4.98%
86
419
812
8553
32
157
866
8815
7
27
891
8945
—
5
26
893
8935
32
145
831
8553
74
381
696
7263
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.3e-01
4.7e-01
7.0e-01
—
8.4e-01
5.8e-01
4.2e-01
cases:20.71%
controls:17.22%
cases:17.15%
controls:11.48%
cases:4.57%
controls:2.33%
—
—
cases:4.45%
controls:1.96%
cases:19.47%
controls:11.92%
cases:31.69%
controls:23.34%
186
1545
712
7427
154
1030
744
7942
41
209
857
8763
—
40
176
858
8785
168
1037
695
7661
244
1784
526
5860
gabapentin; oral
N02BF01 [955005]
1.1e+00
5.8e-01
—
—
1.2e+00
9.2e-01
9.8e-01
cases:4.12%
controls:1.40%
cases:1.56%
controls:0.88%
—
—
—
—
cases:0.78%
controls:0.25%
cases:2.09%
controls:0.84%
cases:5.19%
controls:2.01%
37
126
861
8846
14
79
884
8893
—
—
7
22
891
8939
18
73
845
8625
40
154
730
7490
Ultrasound examination of lower leg veins
PH2AE [2001309451]
4.5e-01
1.5e+00
—
—
—
1.7e+00
1.3e+00
cases:0.89%
controls:0.57%
cases:0.56%
controls:0.12%
—
—
—
—
—
—
cases:1.04%
controls:0.18%
cases:1.82%
controls:0.52%
8
51
890
8921
5
11
893
8961
—
—
—
9
16
854
8682
14
40
756
7604
triamcinolone and antiseptics
D07BB03 [21602150]
5.9e-01
1.0e+00
—
—
—
1.1e+00
8.4e-01
cases:3.34%
controls:1.87%
cases:1.78%
controls:0.65%
—
—
—
—
—
—
cases:1.51%
controls:0.49%
cases:4.16%
controls:1.83%
30
168
868
8804
16
58
882
8914
—
—
—
13
43
850
8655
32
140
738
7504
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.5e-01
5.0e-01
6.7e-01
—
9.0e-01
6.1e-01
5.2e-01
cases:18.71%
controls:12.78%
cases:10.91%
controls:6.90%
cases:2.34%
controls:1.21%
—
—
cases:2.45%
controls:1.02%
cases:11.59%
controls:6.66%
cases:22.86%
controls:14.98%
168
1147
730
7825
98
619
800
8353
21
109
877
8863
—
22
91
876
8870
100
579
763
8119
176
1145
594
6499
Functional capacity evaluation
443351003 [40481051]
7.8e-01
1.9e+00
—
—
—
—
1.0e+00
cases:1.89%
controls:0.88%
cases:1.34%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.21%
controls:0.78%
17
79
881
8893
12
19
886
8953
—
—
—
—
17
60
753
7584
Recurrent depressive disorder, unspecified
F33.9 [45581458]
8.5e-01
1.2e+00
—
—
—
1.7e+00
1.2e+00
cases:1.78%
controls:0.77%
cases:1.11%
controls:0.32%
—
—
—
—
—
—
cases:1.39%
controls:0.25%
cases:2.60%
controls:0.84%
16
69
882
8903
10
29
888
8943
—
—
—
12
22
851
8676
20
64
750
7580
melatonin; oral
N05CH01 [21604659]
6.4e-01
7.3e-01
1.0e+00
—
—
8.6e-01
6.3e-01
cases:4.45%
controls:2.41%
cases:3.12%
controls:1.53%
cases:0.89%
controls:0.32%
—
—
—
—
cases:3.94%
controls:1.70%
cases:6.49%
controls:3.57%
40
216
858
8756
28
137
870
8835
8
29
890
8943
—
—
34
148
829
8550
50
273
720
7371
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
2.8e-01
6.8e-01
9.7e-01
—
9.2e-01
3.4e-01
2.8e-01
cases:21.27%
controls:16.91%
cases:16.15%
controls:8.87%
cases:2.90%
controls:1.11%
—
—
cases:2.45%
controls:0.99%
cases:12.63%
controls:9.29%
cases:31.04%
controls:25.47%
191
1517
707
7455
145
796
753
8176
26
100
872
8872
—
22
89
876
8872
109
808
754
7890
239
1947
531
5697
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
2.8e-01
7.1e-01
9.6e-01
—
8.5e-01
3.5e-01
3.0e-01
cases:21.83%
controls:17.38%
cases:17.82%
controls:9.62%
cases:3.12%
controls:1.21%
—
—
cases:2.45%
controls:1.06%
cases:13.56%
controls:9.99%
cases:32.47%
controls:26.19%
196
1559
702
7413
160
863
738
8109
28
109
870
8863
—
22
95
876
8866
117
869
746
7829
250
2002
520
5642
empagliflozin; oral
A10BK03 [1123740]
1.5e+00
1.2e+00
1.7e+00
—
—
1.0e+00
1.3e+00
cases:1.45%
controls:0.33%
cases:1.11%
controls:0.32%
cases:0.67%
controls:0.12%
—
—
—
—
cases:0.81%
controls:0.29%
cases:1.69%
controls:0.44%
13
30
885
8942
10
29
888
8943
6
11
892
8961
—
—
7
25
856
8673
13
34
757
7610
Female infertility associated with anovulation
N97.0 [45592162]
1.3e+00
—
—
1.0e+50
—
1.4e+00
1.4e+00
cases:1.78%
controls:0.47%
—
—
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.93%
controls:0.23%
cases:2.60%
controls:0.64%
16
42
882
8930
—
—
5
0
893
8972
—
8
20
855
8678
20
49
750
7595
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
6.9e-01
7.2e-01
—
—
—
1.2e+00
8.7e-01
cases:4.34%
controls:2.22%
cases:1.34%
controls:0.66%
—
—
—
—
—
—
cases:1.97%
controls:0.61%
cases:6.10%
controls:2.66%
39
199
859
8773
12
59
886
8913
—
—
—
17
53
846
8645
47
203
723
7441
hydrochlorothiazide; oral
C03AA03 [21601466]
1.2e+00
1.5e+00
—
—
—
9.3e-01
8.5e-01
cases:1.78%
controls:0.53%
cases:1.34%
controls:0.31%
—
—
—
—
—
—
cases:0.93%
controls:0.37%
cases:1.82%
controls:0.78%
16
48
882
8924
12
28
886
8944
—
—
—
8
32
855
8666
14
60
756
7584
Cutaneous abscess, furuncle and carbuncle of limb
L02.4 [45552967]
—
—
—
—
—
2.7e+00
9.6e-01
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.06%
cases:0.78%
controls:0.30%
—
—
—
—
—
7
5
856
8693
6
23
764
7621
Depressive episode, unspecified
F32.9 [45571760]
6.4e-01
1.1e+00
—
—
1.3e+00
6.9e-01
9.5e-01
cases:4.57%
controls:2.45%
cases:2.56%
controls:0.90%
—
—
—
—
cases:0.89%
controls:0.26%
cases:1.85%
controls:0.94%
cases:7.01%
controls:2.84%
41
220
857
8752
23
81
875
8891
—
—
8
23
890
8938
16
82
847
8616
54
217
716
7427
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
3.4e-01
7.5e-01
1.2e+00
—
8.2e-01
3.4e-01
3.2e-01
cases:21.05%
controls:15.98%
cases:14.14%
controls:7.22%
cases:2.90%
controls:0.86%
—
—
cases:1.78%
controls:0.79%
cases:10.20%
controls:7.50%
cases:28.05%
controls:22.03%
189
1434
709
7538
127
648
771
8324
26
77
872
8895
—
16
71
882
8890
88
652
775
8046
216
1684
554
5960
Menstruation absent/scanty
X05 [2002001290]
1.1e+00
2.6e+00
—
—
—
-1.0e+50
1.6e+00
cases:1.00%
controls:0.33%
cases:0.78%
controls:0.06%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.65%
controls:0.13%
9
30
889
8942
7
5
891
8967
—
—
—
0
6
863
8692
5
10
765
7634
Hidradenitis suppurativa
L73.2 [45557711]
—
1.0e+50
—
—
—
—
2.6e+00
—
—
cases:0.89%
controls:0.00%
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.07%
—
8
0
890
8972
—
—
—
—
7
5
763
7639
isotretinoin; oral
D10BA01 [21602320]
9.8e-01
1.7e+00
—
—
—
1.1e+00
6.5e-01
cases:2.90%
controls:1.10%
cases:1.89%
controls:0.37%
—
—
—
—
—
—
cases:1.16%
controls:0.40%
cases:1.82%
controls:0.95%
26
99
872
8873
17
33
881
8939
—
—
—
10
35
853
8663
14
73
756
7571
Outpatient Hospital
22 [8756]
2.0e-01
1.4e-01
2.4e-01
—
1.4e+00
8.2e-01
3.8e-01
cases:25.17%
controls:21.54%
cases:6.46%
controls:5.65%
cases:0.89%
controls:0.70%
—
—
cases:1.89%
controls:0.46%
cases:10.78%
controls:5.05%
cases:23.90%
controls:17.67%
226
1933
672
7039
58
507
840
8465
8
63
890
8909
—
17
41
881
8920
93
439
770
8259
184
1351
586
6293
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.0e-01
5.8e-01
1.4e+00
—
1.7e+00
7.4e-01
4.6e-01
cases:8.13%
controls:5.62%
cases:3.90%
controls:2.22%
cases:1.11%
controls:0.27%
—
—
cases:0.78%
controls:0.15%
cases:4.87%
controls:2.38%
cases:10.26%
controls:6.75%
73
504
825
8468
35
199
863
8773
10
24
888
8948
—
7
13
891
8948
42
207
821
8491
79
516
691
7128
Remote contact by phone
ZYC01 [2001311579]
8.9e-01
9.2e-01
—
—
—
1.4e+00
1.2e+00
cases:1.45%
controls:0.60%
cases:0.56%
controls:0.22%
—
—
—
—
—
—
cases:1.16%
controls:0.30%
cases:1.82%
controls:0.54%
13
54
885
8918
5
20
893
8952
—
—
—
10
26
853
8672
14
41
756
7603
Post-traumatic stress disorder
F43.1 [45595909]
9.1e-01
1.2e+00
—
—
1.7e+00
1.4e+00
1.2e+00
cases:1.67%
controls:0.68%
cases:1.00%
controls:0.31%
—
—
—
—
cases:0.67%
controls:0.12%
cases:1.39%
controls:0.33%
cases:2.08%
controls:0.67%
15
61
883
8911
9
28
889
8944
—
—
6
11
892
8950
12
29
851
8669
16
51
754
7593
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
5.6e-01
1.2e+00
—
—
—
1.4e+00
1.2e+00
cases:1.34%
controls:0.77%
cases:1.11%
controls:0.32%
—
—
—
—
—
—
cases:1.27%
controls:0.33%
cases:2.47%
controls:0.77%
12
69
886
8903
10
29
888
8943
—
—
—
11
29
852
8669
19
59
751
7585
hydrocortisone butyrate
D07AB02 [21602106]
4.0e-01
5.8e-01
6.9e-01
—
1.5e+00
8.8e-01
6.6e-01
cases:10.47%
controls:7.28%
cases:4.79%
controls:2.73%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.13%
cases:12.08%
controls:6.65%
94
653
804
8319
43
245
855
8727
5
25
893
8947
—
9
21
889
8940
43
185
820
8513
93
508
677
7136
hydrocortisone
D07AA02 [21602102]
4.0e-01
5.8e-01
6.9e-01
—
1.5e+00
8.8e-01
6.6e-01
cases:10.47%
controls:7.28%
cases:4.79%
controls:2.73%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.13%
cases:12.08%
controls:6.65%
94
653
804
8319
43
245
855
8727
5
25
893
8947
—
9
21
889
8940
43
185
820
8513
93
508
677
7136
hydrocortisone aceponate
D07AC16 [21602135]
4.0e-01
5.8e-01
6.9e-01
—
1.5e+00
8.8e-01
6.6e-01
cases:10.47%
controls:7.28%
cases:4.79%
controls:2.73%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.13%
cases:12.08%
controls:6.65%
94
653
804
8319
43
245
855
8727
5
25
893
8947
—
9
21
889
8940
43
185
820
8513
93
508
677
7136
hydrocortisone buteprate
D07AB11 [21602115]
4.0e-01
5.8e-01
6.9e-01
—
1.5e+00
8.8e-01
6.6e-01
cases:10.47%
controls:7.28%
cases:4.79%
controls:2.73%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.13%
cases:12.08%
controls:6.65%
94
653
804
8319
43
245
855
8727
5
25
893
8947
—
9
21
889
8940
43
185
820
8513
93
508
677
7136
Dissociative [conversion] disorder, unspecified
F44.9 [45605495]
—
2.5e+00
—
—
—
2.0e+00
—
—
—
cases:0.67%
controls:0.06%
—
—
—
—
—
—
cases:0.58%
controls:0.08%
—
—
—
6
5
892
8967
—
—
—
5
7
858
8691
—
Plastic And Reconstructive Surgery
24 [38004467]
5.5e-01
6.8e-01
—
1.0e+50
—
1.5e+00
9.8e-01
cases:3.56%
controls:2.08%
cases:1.89%
controls:0.97%
—
—
cases:1.45%
controls:0.00%
—
—
cases:4.06%
controls:0.93%
cases:6.49%
controls:2.54%
32
187
866
8785
17
87
881
8885
—
13
0
885
8972
—
35
81
828
8617
50
194
720
7450
Psychological sympt/compl other
P29 [2002000823]
6.1e-01
1.4e+00
—
—
—
1.1e+00
4.7e-01
cases:2.23%
controls:1.23%
cases:2.23%
controls:0.57%
—
—
—
—
—
—
cases:2.09%
controls:0.71%
cases:3.12%
controls:1.96%
20
110
878
8862
20
51
878
8921
—
—
—
18
62
845
8636
24
150
746
7494
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
3.3e-01
5.1e-01
1.0e+00
—
9.4e-01
6.0e-01
2.3e-01
cases:16.70%
controls:12.55%
cases:9.24%
controls:5.75%
cases:1.67%
controls:0.61%
—
—
cases:1.22%
controls:0.48%
cases:9.50%
controls:5.43%
cases:20.00%
controls:16.60%
150
1126
748
7846
83
516
815
8456
15
55
883
8917
—
11
43
887
8918
82
472
781
8226
154
1269
616
6375
Physiotherapist
Z3226 [2001311560]
6.1e-01
1.1e+00
—
—
—
1.4e+00
1.0e+00
cases:2.78%
controls:1.53%
cases:0.89%
controls:0.31%
—
—
—
—
—
—
cases:1.27%
controls:0.31%
cases:2.60%
controls:0.94%
25
137
873
8835
8
28
890
8944
—
—
—
11
27
852
8671
20
72
750
7572
Deviated nasal septum
J34.2 [45562448]
—
—
—
—
—
2.5e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.08%
cases:0.78%
controls:0.21%
—
—
—
—
—
8
7
855
8691
6
16
764
7628
Migraine without aura [common migraine]
G43.0 [45600784]
7.4e-01
1.0e+00
—
—
—
1.4e+00
5.1e-01
cases:2.56%
controls:1.24%
cases:1.67%
controls:0.61%
—
—
—
—
—
—
cases:2.32%
controls:0.56%
cases:3.38%
controls:2.05%
23
111
875
8861
15
55
883
8917
—
—
—
20
49
843
8649
26
157
744
7487
Social phobias
F40.1 [45595907]
1.1e+00
7.4e-01
—
—
—
1.3e+00
1.4e+00
cases:1.56%
controls:0.55%
cases:0.56%
controls:0.27%
—
—
—
—
—
—
cases:0.81%
controls:0.23%
cases:2.21%
controls:0.56%
14
49
884
8923
5
24
893
8948
—
—
—
7
20
856
8678
17
43
753
7601
Macroprolactin [Presence] in Serum or Plasma
72680-2 [43055514]
—
—
1.0e+50
—
—
1.0e+50
2.4e+00
—
—
—
—
cases:0.89%
controls:0.00%
—
—
—
—
cases:0.81%
controls:0.00%
cases:1.04%
controls:0.09%
—
—
8
0
890
8972
—
—
7
0
856
8698
8
7
762
7637
duloxetine; oral
N06AX21 [21604749]
1.1e+00
9.8e-01
—
—
1.2e+00
5.4e-01
1.3e+00
cases:3.45%
controls:1.19%
cases:1.56%
controls:0.59%
—
—
—
—
cases:0.78%
controls:0.23%
cases:1.27%
controls:0.75%
cases:4.55%
controls:1.26%
31
107
867
8865
14
53
884
8919
—
—
7
21
891
8940
11
65
852
8633
35
96
735
7548
Medical doctor
Z2221 [2001311556]
1.1e-01
7.7e-01
—
1.0e+50
1.3e+00
1.5e+00
9.2e-01
cases:5.01%
controls:4.53%
cases:2.23%
controls:1.05%
—
—
cases:4.45%
controls:0.00%
cases:0.67%
controls:0.18%
cases:4.52%
controls:1.07%
cases:7.14%
controls:2.97%
45
406
853
8566
20
94
878
8878
—
40
0
858
8972
6
16
892
8945
39
93
824
8605
55
227
715
7417
Intravenous general anesthesia
WX404 [2001310807]
6.8e-02
5.3e-01
-1.0e+50
—
—
1.5e+00
9.1e-01
cases:2.56%
controls:2.40%
cases:1.00%
controls:0.59%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.74%
controls:0.40%
cases:2.99%
controls:1.23%
23
215
875
8757
9
53
889
8919
0
7
898
8965
—
—
15
35
848
8663
23
94
747
7550
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
8.6e-01
1.8e+00
—
—
—
2.3e+00
1.1e+00
cases:1.22%
controls:0.52%
cases:0.56%
controls:0.09%
—
—
—
—
—
—
cases:0.81%
controls:0.08%
cases:1.04%
controls:0.35%
11
47
887
8925
5
8
893
8964
—
—
—
7
7
856
8691
8
27
762
7617
Clinic/Center
261Q00000X [38004207]
8.5e-01
—
-1.0e+50
—
-1.0e+50
2.3e+00
1.1e+00
cases:1.11%
controls:0.48%
—
—
cases:0.00%
controls:0.08%
—
—
cases:0.00%
controls:0.06%
cases:0.81%
controls:0.08%
cases:0.65%
controls:0.22%
10
43
888
8929
—
0
7
898
8965
—
0
5
898
8956
7
7
856
8691
5
17
765
7627
glimepiride; oral
A10BB12 [21600761]
1.5e+00
—
—
—
—
—
2.3e+00
cases:0.56%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.12%
5
11
893
8961
—
—
—
—
—
9
9
761
7635
Non-real-time text-based remote communication
ZYC05 [2001311583]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.08%
—
—
—
—
—
—
6
6
764
7638
PEEP
WX722 [2001310825]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.08%
—
—
—
—
—
—
6
6
764
7638
pH of Specimen
17433-4 [3019225]
1.0e+00
1.0e+00
—
—
—
1.2e+00
1.3e+00
cases:2.67%
controls:1.00%
cases:1.22%
controls:0.45%
—
—
—
—
—
—
cases:0.93%
controls:0.28%
cases:2.86%
controls:0.80%
24
90
874
8882
11
40
887
8932
—
—
—
8
24
855
8674
22
61
748
7583
General Surgery
2 [38004447]
3.5e-01
5.4e-01
4.7e-01
—
1.0e+00
8.1e-01
5.7e-01
cases:14.92%
controls:11.03%
cases:6.35%
controls:3.79%
cases:0.78%
controls:0.49%
—
—
cases:1.45%
controls:0.51%
cases:7.42%
controls:3.45%
cases:17.66%
controls:10.83%
134
990
764
7982
57
340
841
8632
7
44
891
8928
—
13
46
885
8915
64
300
799
8398
136
828
634
6816
semaglutide; oral, parenteral
A10BJ06 [1501778]
8.1e-01
6.4e-01
—
—
8.8e-01
1.0e+00
1.2e+00
cases:1.22%
controls:0.55%
cases:1.22%
controls:0.65%
—
—
—
—
cases:0.67%
controls:0.28%
cases:2.32%
controls:0.85%
cases:4.55%
controls:1.36%
11
49
887
8923
11
58
887
8914
—
—
6
25
892
8936
20
74
843
8624
35
104
735
7540
Generalized anxiety disorder
F41.1 [45571764]
4.2e-01
7.3e-01
—
—
—
1.5e+00
7.8e-01
cases:1.78%
controls:1.18%
cases:1.34%
controls:0.65%
—
—
—
—
—
—
cases:2.32%
controls:0.55%
cases:3.38%
controls:1.58%
16
106
882
8866
12
58
886
8914
—
—
—
20
48
843
8650
26
121
744
7523
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
5.7e-01
1.1e-01
—
—
—
9.3e-01
7.2e-01
cases:5.12%
controls:2.96%
cases:1.34%
controls:1.20%
—
—
—
—
—
—
cases:2.67%
controls:1.07%
cases:6.75%
controls:3.40%
46
266
852
8706
12
108
886
8864
—
—
—
23
93
840
8605
52
260
718
7384
amitriptyline and psycholeptics
N06CA01 [21604789]
5.2e-01
7.9e-01
—
—
-1.0e+50
1.2e+00
9.7e-01
cases:1.89%
controls:1.14%
cases:1.00%
controls:0.46%
—
—
—
—
cases:0.00%
controls:0.12%
cases:1.39%
controls:0.40%
cases:2.21%
controls:0.85%
17
102
881
8870
9
41
889
8931
—
—
0
11
898
8950
12
35
851
8663
17
65
753
7579
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.5e-01
5.0e-01
6.8e-01
—
1.3e+00
5.2e-01
4.6e-01
cases:10.24%
controls:6.81%
cases:5.12%
controls:3.18%
cases:1.00%
controls:0.51%
—
—
cases:1.34%
controls:0.37%
cases:4.87%
controls:2.95%
cases:12.86%
controls:8.50%
92
611
806
8361
46
285
852
8687
9
46
889
8926
—
12
33
886
8928
42
257
821
8441
99
650
671
6994
furosemide; oral, parenteral
C03CA01 [21601518]
8.4e-01
7.5e-01
—
—
—
7.2e-01
1.4e+00
cases:2.34%
controls:1.03%
cases:1.45%
controls:0.69%
—
—
—
—
—
—
cases:1.39%
controls:0.68%
cases:4.29%
controls:1.14%
21
92
877
8880
13
62
885
8910
—
—
—
12
59
851
8639
33
87
737
7557
Estimation of glomerular filtration rate
791801000000102 [44806420]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.12%
0
17
898
8955
—
—
—
—
—
8
9
762
7635
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
2.3e-01
3.6e-01
5.4e-01
—
1.5e+00
1.3e+00
8.4e-01
cases:10.13%
controls:8.24%
cases:4.23%
controls:3.00%
cases:0.67%
controls:0.39%
—
—
cases:1.00%
controls:0.23%
cases:9.97%
controls:2.81%
cases:15.97%
controls:7.59%
91
739
807
8233
38
269
860
8703
6
35
892
8937
—
9
21
889
8940
86
244
777
8454
123
580
647
7064
Hysteroscopy
ULC02 [2001306644]
9.6e-01
—
—
—
—
2.2e+00
6.9e-01
cases:0.78%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.09%
cases:0.91%
controls:0.46%
7
27
891
8945
—
—
—
—
7
8
856
8690
7
35
763
7609
fluoxetine; oral
N06AB03 [21604711]
1.0e+00
8.3e-01
—
—
8.4e-01
9.1e-01
1.2e+00
cases:4.23%
controls:1.59%
cases:2.00%
controls:0.88%
—
—
—
—
cases:0.67%
controls:0.29%
cases:1.97%
controls:0.80%
cases:4.55%
controls:1.45%
38
143
860
8829
18
79
880
8893
—
—
6
26
892
8935
17
70
846
8628
35
111
735
7533
Androstenedione [Moles/volume] in Serum or Plasma
14603-5 [3022411]
2.2e+00
—
1.0e+50
1.0e+50
1.0e+50
—
—
cases:0.78%
controls:0.09%
—
—
cases:5.46%
controls:0.00%
cases:0.56%
controls:0.00%
cases:3.34%
controls:0.00%
—
—
—
—
7
8
891
8964
—
49
0
849
8972
5
0
893
8972
30
0
868
8961
—
—
Endometrial glandular hyperplasia
N85.0 [45606511]
—
—
—
—
—
1.0e+50
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.00%
cases:0.91%
controls:0.10%
—
—
—
—
—
5
0
858
8698
7
8
763
7636
fluconazole; oral, parenteral
J02AC01 [21603080]
3.5e-01
4.9e-01
2.4e-01
—
6.3e-01
8.2e-01
5.0e-01
cases:14.25%
controls:10.49%
cases:6.35%
controls:3.97%
cases:0.67%
controls:0.52%
—
—
cases:1.00%
controls:0.54%
cases:8.00%
controls:3.69%
cases:17.01%
controls:11.05%
128
941
770
8031
57
356
841
8616
6
47
892
8925
—
9
48
889
8913
69
321
794
8377
131
845
639
6799
baclofen; oral, parenteral
M03BX01 [21604115]
2.2e+00
—
—
—
—
—
—
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
892
8965
—
—
—
—
—
—
hydroxyzine; oral, parenteral
N05BB01 [21604590]
3.9e-01
5.6e-01
—
—
—
1.1e+00
1.0e+00
cases:3.56%
controls:2.45%
cases:1.45%
controls:0.84%
—
—
—
—
—
—
cases:2.32%
controls:0.75%
cases:5.84%
controls:2.24%
32
220
866
8752
13
75
885
8897
—
—
—
20
65
843
8633
45
171
725
7473
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
3.4e-01
-1.0e+50
—
—
—
2.1e+00
3.2e-01
cases:0.78%
controls:0.56%
cases:0.00%
controls:0.22%
—
—
—
—
—
—
cases:1.04%
controls:0.13%
cases:1.04%
controls:0.76%
7
50
891
8922
0
20
898
8952
—
—
—
9
11
854
8687
8
58
762
7586
haloperidol; oral, parenteral
N05AD01 [21604516]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.14%
—
—
—
—
—
—
9
11
761
7633
hydrocortisone
A07EA02 [21600654]
3.8e-01
5.7e-01
6.9e-01
—
1.5e+00
8.7e-01
6.6e-01
cases:10.47%
controls:7.39%
cases:4.79%
controls:2.75%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.15%
cases:12.08%
controls:6.65%
94
663
804
8309
43
247
855
8725
5
25
893
8947
—
9
21
889
8940
43
187
820
8511
93
508
677
7136
hydrocortisone
C05AA01 [21601608]
3.8e-01
5.7e-01
6.9e-01
—
1.5e+00
8.7e-01
6.6e-01
cases:10.47%
controls:7.39%
cases:4.79%
controls:2.75%
cases:0.56%
controls:0.28%
—
—
cases:1.00%
controls:0.23%
cases:4.98%
controls:2.15%
cases:12.08%
controls:6.65%
94
663
804
8309
43
247
855
8725
5
25
893
8947
—
9
21
889
8940
43
187
820
8511
93
508
677
7136
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
3.8e-01
5.9e-01
1.0e+00
—
1.3e+00
9.4e-01
5.6e-01
cases:6.90%
controls:4.84%
cases:4.45%
controls:2.51%
cases:1.00%
controls:0.37%
—
—
cases:1.00%
controls:0.27%
cases:5.10%
controls:2.06%
cases:9.87%
controls:5.90%
62
434
836
8538
40
225
858
8747
9
33
889
8939
—
9
24
889
8937
44
179
819
8519
76
451
694
7193
Sleep disturbance
P06 [2002000803]
4.3e-01
4.1e-01
—
—
—
1.4e+00
7.2e-01
cases:2.45%
controls:1.60%
cases:1.00%
controls:0.67%
—
—
—
—
—
—
cases:2.09%
controls:0.54%
cases:4.16%
controls:2.07%
22
144
876
8828
9
60
889
8912
—
—
—
18
47
845
8651
32
158
738
7486
General health counselling
SPAT1312 [2001700413]
2.3e-01
3.0e-01
2.1e+00
—
—
5.8e-01
4.4e-01
cases:9.02%
controls:7.32%
cases:2.78%
controls:2.08%
cases:0.89%
controls:0.11%
—
—
—
—
cases:3.13%
controls:1.77%
cases:7.79%
controls:5.14%
81
657
817
8315
25
187
873
8785
8
10
890
8962
—
—
27
154
836
8544
60
393
710
7251
Guidance concerning rehabilitation services and livelihood
SPAT1221 [2001700322]
2.1e+00
—
—
—
—
-1.0e+50
1.8e+00
cases:0.89%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.65%
controls:0.10%
8
10
890
8962
—
—
—
—
0
5
863
8693
5
8
765
7636
Cutaneous abscess, furuncle and carbuncle
L02 [45538561]
—
2.1e+00
—
—
—
-1.0e+50
1.0e+00
—
—
cases:0.89%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:1.04%
controls:0.37%
—
8
10
890
8962
—
—
—
0
8
863
8690
8
28
762
7616
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
285 [2001600217]
9.7e-01
—
—
—
—
—
2.1e+00
cases:0.56%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.18%
5
19
893
8953
—
—
—
—
—
11
14
759
7630
Other minor procedure on skin
TQW99 [2001310150]
—
—
—
1.0e+50
—
—
2.1e+00
—
—
—
—
—
—
cases:0.89%
controls:0.00%
—
—
—
—
cases:0.91%
controls:0.12%
—
—
—
8
0
890
8972
—
—
7
9
763
7635
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
O24.1 [45534187]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.12%
—
—
—
—
—
—
7
9
763
7635
clobetasol
D07AD01 [21602141]
7.0e-01
4.4e-01
—
—
—
1.1e+00
9.4e-01
cases:2.45%
controls:1.23%
cases:0.78%
controls:0.50%
—
—
—
—
—
—
cases:1.51%
controls:0.51%
cases:3.90%
controls:1.56%
22
110
876
8862
7
45
891
8927
—
—
—
13
44
850
8654
30
119
740
7525
Nail symptom/complaint
S22 [2002000987]
1.1e+00
—
—
—
—
2.0e+00
9.8e-01
cases:1.34%
controls:0.47%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.14%
cases:1.56%
controls:0.59%
12
42
886
8930
—
—
—
—
9
12
854
8686
12
45
758
7599
pioglitazone; oral
A10BG03 [21600782]
2.0e+00
—
—
—
—
—
—
cases:0.67%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
892
8964
—
—
—
—
—
—
clomipramine; oral, parenteral
N06AA04 [21604691]
2.0e+00
—
—
—
—
—
—
cases:0.67%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
892
8964
—
—
—
—
—
—
Pilonidal cyst without abscess
L05.9 [45581935]
1.6e+00
—
—
—
—
—
2.0e+00
cases:0.56%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.10%
5
10
893
8962
—
—
—
—
—
6
8
764
7636
Cramp and spasm
R25.2 [45592414]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.10%
—
—
—
—
—
—
6
8
764
7636
Other therapy enhancing rehabilitation
R4160 [2001310240]
5.5e-01
—
—
—
—
—
2.0e+00
cases:0.56%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.10%
5
29
893
8943
—
—
—
—
—
6
8
764
7636
Scheduled procedure
ZXD10 [2001311387]
1.3e-01
5.7e-01
—
—
—
1.1e+00
9.2e-01
cases:4.90%
controls:4.34%
cases:1.78%
controls:1.01%
—
—
—
—
—
—
cases:2.67%
controls:0.94%
cases:7.53%
controls:3.15%
44
389
854
8583
16
91
882
8881
—
—
—
23
82
840
8616
58
241
712
7403
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
4.8e-01
5.8e-01
1.1e+00
—
—
8.6e-01
6.2e-01
cases:7.02%
controls:4.47%
cases:3.23%
controls:1.83%
cases:0.56%
controls:0.18%
—
—
—
—
cases:4.87%
controls:2.13%
cases:11.43%
controls:6.48%
63
401
835
8571
29
164
869
8808
5
16
893
8956
—
—
42
185
821
8513
88
495
682
7149
Other and unspecified abdominal pain
R10.4 [45568113]
5.6e-01
7.5e-01
—
—
1.4e+00
6.0e-01
6.4e-01
cases:11.14%
controls:6.67%
cases:4.12%
controls:1.98%
—
—
—
—
cases:0.89%
controls:0.21%
cases:3.71%
controls:2.07%
cases:11.95%
controls:6.70%
100
598
798
8374
37
178
861
8794
—
—
8
19
890
8942
32
180
831
8518
92
512
678
7132
Atypical bulimia nervosa
F50.3 [45600752]
2.0e+00
-1.0e+50
—
—
—
—
—
cases:0.78%
controls:0.11%
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
7
10
891
8962
0
6
898
8966
—
—
—
—
—
Cortisol [Moles/volume] in Saliva (oral fluid)
51844-9 [3039429]
2.0e+00
—
1.0e+50
—
1.0e+50
—
1.9e+00
cases:0.56%
controls:0.08%
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.91%
controls:0.13%
5
7
893
8965
—
6
0
892
8972
—
5
0
893
8961
—
7
10
763
7634
candesartan; oral
C09CA06 [21601829]
6.3e-01
7.2e-01
4.1e-01
—
5.3e-01
6.5e-01
5.9e-01
cases:4.23%
controls:2.31%
cases:3.56%
controls:1.77%
cases:0.67%
controls:0.45%
—
—
cases:0.89%
controls:0.52%
cases:3.71%
controls:1.97%
cases:6.88%
controls:3.92%
38
207
860
8765
32
159
866
8813
6
40
892
8932
—
8
47
890
8914
32
171
831
8527
53
300
717
7344
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
9.0e-01
1.1e+00
—
—
—
1.3e+00
1.0e+00
cases:2.45%
controls:1.01%
cases:1.00%
controls:0.35%
—
—
—
—
—
—
cases:1.04%
controls:0.28%
cases:2.21%
controls:0.80%
22
91
876
8881
9
31
889
8941
—
—
—
9
24
854
8674
17
61
753
7583
lymecycline; oral, parenteral
J01AA04 [21602802]
7.9e-01
1.1e+00
—
—
—
4.3e-01
6.8e-01
cases:3.79%
controls:1.76%
cases:1.45%
controls:0.47%
—
—
—
—
—
—
cases:0.81%
controls:0.53%
cases:2.86%
controls:1.47%
34
158
864
8814
13
42
885
8930
—
—
—
7
46
856
8652
22
112
748
7532
Sampling
SPAT1263 [2001700364]
8.9e-02
1.5e-01
2.7e-01
—
1.5e+00
5.9e-01
4.4e-01
cases:10.13%
controls:9.35%
cases:3.45%
controls:2.98%
cases:0.56%
controls:0.42%
—
—
cases:1.22%
controls:0.28%
cases:4.63%
controls:2.63%
cases:12.08%
controls:8.16%
91
839
807
8133
31
267
867
8705
5
38
893
8934
—
11
25
887
8936
40
229
823
8469
93
624
677
7020
Hyperprolactinaemia
E22.1 [45600649]
-1.0e+50
—
—
1.0e+50
—
1.9e+00
1.2e+00
cases:0.00%
controls:0.23%
—
—
—
—
cases:0.89%
controls:0.00%
—
—
cases:0.93%
controls:0.14%
cases:0.65%
controls:0.20%
0
21
898
8951
—
—
8
0
890
8972
—
8
12
855
8686
5
15
765
7629
Emergency Room Visit
ER [9203]
1.9e-01
3.3e-01
1.6e-01
—
1.0e+00
4.9e-01
4.0e-01
cases:34.86%
controls:30.70%
cases:13.70%
controls:10.27%
cases:1.56%
controls:1.34%
—
—
cases:2.78%
controls:1.03%
cases:15.30%
controls:9.92%
cases:37.53%
controls:28.66%
313
2754
585
6218
123
921
775
8051
14
120
884
8852
—
25
92
873
8869
132
863
731
7835
289
2191
481
5453
tizanidine; oral
M03BX02 [21604116]
4.1e-01
5.1e-01
7.3e-01
—
1.8e-02
5.6e-01
4.3e-01
cases:18.93%
controls:13.44%
cases:7.91%
controls:4.90%
cases:1.34%
controls:0.65%
—
—
cases:0.56%
controls:0.55%
cases:8.69%
controls:5.15%
cases:21.17%
controls:14.84%
170
1206
728
7766
71
440
827
8532
12
58
886
8914
—
5
49
893
8912
75
448
788
8250
163
1134
607
6510
tretinoin, combinations; ointment
D10AD51 [21602298]
9.0e-01
1.9e+00
—
—
—
1.3e+00
4.0e-01
cases:1.11%
controls:0.46%
cases:1.11%
controls:0.17%
—
—
—
—
—
—
cases:0.70%
controls:0.20%
cases:0.78%
controls:0.52%
10
41
888
8931
10
15
888
8957
—
—
—
6
17
857
8681
6
40
764
7604
Hypothyroidism, unspecified
E03.9 [45537945]
4.1e-01
6.1e-01
—
—
—
9.1e-01
9.9e-01
cases:2.56%
controls:1.72%
cases:1.45%
controls:0.79%
—
—
—
—
—
—
cases:2.20%
controls:0.90%
cases:5.71%
controls:2.20%
23
154
875
8818
13
71
885
8901
—
—
—
19
78
844
8620
44
168
726
7476
More than one and less than three hours
ZXE10 [2001311401]
4.2e-01
5.6e-01
—
—
—
1.1e+00
8.4e-01
cases:5.23%
controls:3.50%
cases:1.45%
controls:0.84%
—
—
—
—
—
—
cases:2.09%
controls:0.74%
cases:5.45%
controls:2.43%
47
314
851
8658
13
75
885
8897
—
—
—
18
64
845
8634
42
186
728
7458
Pain in limb
M79.6 [45587063]
5.6e-01
7.7e-01
—
—
1.1e+00
6.1e-01
5.6e-01
cases:7.24%
controls:4.26%
cases:3.90%
controls:1.84%
—
—
—
—
cases:0.56%
controls:0.18%
cases:4.06%
controls:2.25%
cases:12.47%
controls:7.54%
65
382
833
8590
35
165
863
8807
—
—
5
16
893
8945
35
196
828
8502
96
576
674
7068
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.8e-01
3.7e-01
6.3e-01
—
2.4e-01
7.0e-01
4.4e-01
cases:32.52%
controls:24.79%
cases:16.48%
controls:12.04%
cases:3.01%
controls:1.63%
—
—
cases:2.23%
controls:1.76%
cases:20.39%
controls:11.32%
cases:39.48%
controls:29.58%
292
2224
606
6748
148
1080
750
7892
27
146
871
8826
—
20
158
878
8803
176
985
687
7713
304
2261
466
5383
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
5.0e-01
6.2e-01
—
—
—
1.0e+00
8.3e-01
cases:3.34%
controls:2.05%
cases:1.89%
controls:1.03%
—
—
—
—
—
—
cases:3.01%
controls:1.08%
cases:7.92%
controls:3.61%
30
184
868
8788
17
92
881
8880
—
—
—
26
94
837
8604
61
276
709
7368
clindamycin, combinations
D10AF51 [21602309]
8.6e-01
1.9e+00
—
—
—
1.2e+00
5.5e-01
cases:1.22%
controls:0.52%
cases:1.22%
controls:0.19%
—
—
—
—
—
—
cases:0.70%
controls:0.22%
cases:1.04%
controls:0.60%
11
47
887
8925
11
17
887
8955
—
—
—
6
19
857
8679
8
46
762
7598
esomeprazole; oral, parenteral
A02BC05 [21600100]
5.7e-01
5.5e-01
—
—
4.6e-01
6.6e-01
6.4e-01
cases:7.68%
controls:4.48%
cases:4.01%
controls:2.35%
—
—
—
—
cases:0.67%
controls:0.42%
cases:4.17%
controls:2.21%
cases:10.91%
controls:6.06%
69
402
829
8570
36
211
862
8761
—
—
6
38
892
8923
36
192
827
8506
84
463
686
7181
Observation for other suspected diseases and conditions
Z03.8 [45585798]
1.1e+00
—
—
—
—
—
1.9e+00
cases:0.89%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.18%
8
28
890
8944
—
—
—
—
—
9
14
761
7630
Other somatoform disorders
F45.8 [45600750]
7.2e-01
7.7e-01
—
—
2.1e+00
9.3e-01
1.1e+00
cases:3.23%
controls:1.59%
cases:0.89%
controls:0.41%
—
—
—
—
cases:0.56%
controls:0.07%
cases:1.04%
controls:0.41%
cases:3.77%
controls:1.24%
29
143
869
8829
8
37
890
8935
—
—
5
6
893
8955
9
36
854
8662
29
95
741
7549
Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
69002-4 [40771527]
1.9e+00
—
—
—
—
—
—
cases:0.78%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
891
8961
—
—
—
—
—
—
Personality disorder, unspecified
F60.9 [45538076]
1.1e+00
—
—
—
—
—
1.9e+00
cases:0.56%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.14%
5
17
893
8955
—
—
—
—
—
7
11
763
7633
Laparoscopic gastric bypass
JDF11 [2001304736]
1.7e+00
—
—
—
—
—
1.9e+00
cases:0.56%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.14%
5
9
893
8963
—
—
—
—
—
7
11
763
7633
Nutritional therapy
R4190 [2001310243]
8.4e-01
—
—
—
—
1.8e+00
1.0e+00
cases:0.67%
controls:0.29%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.18%
cases:1.04%
controls:0.38%
6
26
892
8946
—
—
—
—
10
16
853
8682
8
29
762
7615
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.8e+00
1.3e+00
—
—
—
1.6e+00
8.5e-01
cases:1.67%
controls:0.27%
cases:0.56%
controls:0.16%
—
—
—
—
—
—
cases:0.81%
controls:0.16%
cases:1.04%
controls:0.44%
15
24
883
8948
5
14
893
8958
—
—
—
7
14
856
8684
8
34
762
7610
Emotionally unstable personality disorder
F60.3 [45566852]
1.8e+00
-1.0e+50
—
—
—
—
1.9e+00
cases:1.11%
controls:0.18%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.12%
10
16
888
8956
0
10
898
8962
—
—
—
—
6
9
764
7635
sertraline; oral
N06AB06 [21604714]
5.6e-01
6.6e-01
9.6e-01
—
4.2e-01
8.0e-01
1.0e+00
cases:3.56%
controls:2.06%
cases:2.45%
controls:1.28%
cases:0.78%
controls:0.30%
—
—
cases:0.78%
controls:0.51%
cases:2.78%
controls:1.26%
cases:7.53%
controls:2.81%
32
185
866
8787
22
115
876
8857
7
27
891
8945
—
7
46
891
8915
24
110
839
8588
58
215
712
7429
Dizziness and giddiness
R42 [45568132]
5.9e-01
9.7e-01
—
—
1.8e+00
5.8e-01
8.3e-01
cases:3.45%
controls:1.94%
cases:1.78%
controls:0.68%
—
—
—
—
cases:0.67%
controls:0.11%
cases:1.04%
controls:0.59%
cases:5.06%
controls:2.26%
31
174
867
8798
16
61
882
8911
—
—
6
10
892
8951
9
51
854
8647
39
173
731
7471
Dentistry
C5 [903277]
3.6e-01
7.5e-01
—
—
—
1.0e+00
7.6e-01
cases:3.34%
controls:2.35%
cases:1.78%
controls:0.85%
—
—
—
—
—
—
cases:2.32%
controls:0.83%
cases:4.03%
controls:1.92%
30
211
868
8761
16
76
882
8896
—
—
—
20
72
843
8626
31
147
739
7497
Gastroenterology
10 [38004455]
1.7e-01
6.8e-01
6.2e-01
—
—
9.7e-01
8.2e-01
cases:3.79%
controls:3.22%
cases:2.56%
controls:1.32%
cases:0.56%
controls:0.30%
—
—
—
—
cases:3.36%
controls:1.30%
cases:7.53%
controls:3.45%
34
289
864
8683
23
118
875
8854
5
27
893
8945
—
—
29
113
834
8585
58
264
712
7380
Spirometry at the office
SPAT1059 [2001700160]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.20%
—
—
—
—
—
—
9
15
761
7629
cefalexin; oral
J01DB01 [21602870]
3.1e-01
4.7e-01
2.7e-01
—
7.3e-01
6.0e-01
4.1e-01
cases:35.19%
controls:28.46%
cases:14.03%
controls:9.26%
cases:1.22%
controls:0.94%
—
—
cases:1.67%
controls:0.81%
cases:14.83%
controls:8.71%
cases:37.79%
controls:28.75%
316
2553
582
6419
126
831
772
8141
11
84
887
8888
—
15
73
883
8888
128
758
735
7940
291
2198
479
5446
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
2.2e-01
-9.0e-04
—
—
1.7e+00
1.8e+00
5.9e-01
cases:2.45%
controls:1.98%
cases:0.78%
controls:0.78%
—
—
—
—
cases:0.56%
controls:0.10%
cases:4.06%
controls:0.70%
cases:4.03%
controls:2.28%
22
178
876
8794
7
70
891
8902
—
—
5
9
893
8952
35
61
828
8637
31
174
739
7470
estriol; oral, parenteral, vaginal
G03CA04 [21602518]
7.7e-01
1.8e+00
—
—
—
1.5e+00
9.8e-01
cases:1.00%
controls:0.47%
cases:0.78%
controls:0.13%
—
—
—
—
—
—
cases:0.70%
controls:0.15%
cases:1.56%
controls:0.59%
9
42
889
8930
7
12
891
8960
—
—
—
6
13
857
8685
12
45
758
7599
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.16%
—
—
—
—
—
—
7
12
763
7632
Schizophrenia, unspecified
F20.9 [45576533]
1.2e+00
—
—
—
—
—
1.8e+00
cases:0.56%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.16%
5
15
893
8957
—
—
—
—
—
7
12
763
7632
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.7e-01
8.1e-01
—
—
—
1.2e+00
4.7e-01
cases:4.79%
controls:2.75%
cases:2.00%
controls:0.90%
—
—
—
—
—
—
cases:3.24%
controls:1.01%
cases:5.19%
controls:3.30%
43
247
855
8725
18
81
880
8891
—
—
—
28
88
835
8610
40
252
730
7392
losartan; oral
C09CA01 [21601824]
6.3e-01
8.2e-01
4.7e-01
—
7.8e-01
7.7e-01
9.3e-01
cases:2.78%
controls:1.50%
cases:2.90%
controls:1.29%
cases:0.78%
controls:0.49%
—
—
cases:0.78%
controls:0.36%
cases:2.55%
controls:1.20%
cases:4.42%
controls:1.79%
25
135
873
8837
26
116
872
8856
7
44
891
8928
—
7
32
891
8929
22
104
841
8594
34
137
736
7507
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
1.7e+00
—
—
—
—
—
—
cases:0.89%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
8
14
890
8958
—
—
—
—
—
—
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
8.2e-01
6.5e-01
—
—
—
5.2e-01
9.2e-01
cases:3.45%
controls:1.55%
cases:1.00%
controls:0.52%
—
—
—
—
—
—
cases:0.81%
controls:0.48%
cases:4.42%
controls:1.81%
31
139
867
8833
9
47
889
8925
—
—
—
7
42
856
8656
34
138
736
7506
tolfenamic acid; oral, rectal
M01AG02 [21603988]
1.2e-01
9.7e-01
—
—
—
9.3e-01
7.7e-01
cases:3.01%
controls:2.69%
cases:1.89%
controls:0.72%
—
—
—
—
—
—
cases:1.51%
controls:0.60%
cases:3.38%
controls:1.60%
27
241
871
8731
17
65
881
8907
—
—
—
13
52
850
8646
26
122
744
7522
Postmenopausal bleeding
N95.0 [45567872]
1.7e+00
—
—
—
—
—
1.0e+00
cases:1.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.38%
9
16
889
8956
—
—
—
—
—
8
29
762
7615
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
346 [2001600307]
1.1e+00
—
—
—
—
—
1.7e+00
cases:0.56%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.21%
5
17
893
8955
—
—
—
—
—
9
16
761
7628
Thorax X-ray examination
GD1AA [2001303617]
5.5e-01
3.0e-01
—
—
—
1.2e+00
5.6e-01
cases:5.68%
controls:3.37%
cases:1.67%
controls:1.25%
—
—
—
—
—
—
cases:2.90%
controls:0.91%
cases:5.71%
controls:3.35%
51
302
847
8670
15
112
883
8860
—
—
—
25
79
838
8619
44
256
726
7388
Infiltration anesthesia
WX110 [2001310767]
2.2e-01
3.3e-01
1.5e-01
—
8.8e-01
5.5e-01
3.0e-01
cases:22.72%
controls:19.05%
cases:10.58%
controls:7.82%
cases:0.89%
controls:0.77%
—
—
cases:2.12%
controls:0.89%
cases:12.05%
controls:7.36%
cases:26.36%
controls:20.92%
204
1709
694
7263
95
702
803
8270
8
69
890
8903
—
19
80
879
8881
104
640
759
8058
203
1599
567
6045
temazepam; oral
N05CD07 [21604642]
9.0e-01
6.5e-01
—
—
—
6.6e-01
8.2e-01
cases:4.23%
controls:1.76%
cases:1.78%
controls:0.94%
—
—
—
—
—
—
cases:1.85%
controls:0.97%
cases:3.64%
controls:1.64%
38
158
860
8814
16
84
882
8888
—
—
—
16
84
847
8614
28
125
742
7519
betamethasone
S03BA03 [21605203]
8.2e-01
5.9e-01
—
—
—
7.4e-01
8.9e-01
cases:3.56%
controls:1.59%
cases:1.34%
controls:0.75%
—
—
—
—
—
—
cases:1.39%
controls:0.67%
cases:4.55%
controls:1.91%
32
143
866
8829
12
67
886
8905
—
—
—
12
58
851
8640
35
146
735
7498
Schizoaffective disorder, unspecified
F25.9 [45605490]
1.3e+00
1.4e+00
—
—
—
1.4e+00
1.7e+00
cases:0.78%
controls:0.22%
cases:0.56%
controls:0.13%
—
—
—
—
—
—
cases:0.58%
controls:0.14%
cases:1.30%
controls:0.24%
7
20
891
8952
5
12
893
8960
—
—
—
5
12
858
8686
10
18
760
7626
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
7.8e-01
7.0e-01
—
—
-1.0e+50
6.0e-01
9.3e-01
cases:3.45%
controls:1.60%
cases:1.00%
controls:0.50%
—
—
—
—
cases:0.00%
controls:0.10%
cases:0.81%
controls:0.45%
cases:3.38%
controls:1.36%
31
144
867
8828
9
45
889
8927
—
—
0
9
898
8952
7
39
856
8659
26
104
744
7540
Candidiasis of vulva and vagina
B37.3 [45605230]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.26%
—
—
—
—
—
—
11
20
759
7624
Pruritus
S02 [2002000967]
7.6e-01
—
—
—
—
—
1.7e+00
cases:0.67%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.29%
6
28
892
8944
—
—
—
—
—
12
22
758
7622
Pulmonary Disease
29 [38004472]
7.6e-01
5.7e-01
—
—
3.6e-01
6.5e-01
9.4e-01
cases:7.24%
controls:3.52%
cases:3.34%
controls:1.92%
—
—
—
—
cases:0.67%
controls:0.47%
cases:3.48%
controls:1.84%
cases:9.48%
controls:3.94%
65
316
833
8656
30
172
868
8800
—
—
6
42
892
8919
30
160
833
8538
73
301
697
7343
clindamycin; oral, parenteral
J01FF01 [21602985]
6.8e-01
5.4e-01
—
—
—
1.0e+00
4.8e-01
cases:5.12%
controls:2.67%
cases:1.34%
controls:0.78%
—
—
—
—
—
—
cases:1.97%
controls:0.72%
cases:4.68%
controls:2.96%
46
240
852
8732
12
70
886
8902
—
—
—
17
63
846
8635
36
226
734
7418
metronidazole; oral, rectal
P01AB01 [21604857]
4.5e-01
3.3e-01
—
—
—
7.8e-01
4.5e-01
cases:12.81%
controls:8.57%
cases:3.67%
controls:2.66%
—
—
—
—
—
—
cases:4.63%
controls:2.17%
cases:12.34%
controls:8.20%
115
769
783
8203
33
239
865
8733
—
—
—
40
189
823
8509
95
627
675
7017
Irregular menstruation, unspecified
N92.6 [45539075]
6.1e-01
1.7e+00
—
—
—
3.4e-01
5.2e-01
cases:2.45%
controls:1.35%
cases:2.34%
controls:0.45%
—
—
—
—
—
—
cases:0.58%
controls:0.41%
cases:2.60%
controls:1.56%
22
121
876
8851
21
40
877
8932
—
—
—
5
36
858
8662
20
119
750
7525
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.20%
—
—
—
—
—
—
8
15
762
7629
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.7e+00
—
—
—
—
—
—
cases:1.34%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
12
23
886
8949
—
—
—
—
—
—
Social worker
Z2446 [2001311559]
8.9e-01
1.4e+00
—
—
—
1.5e+00
1.7e+00
cases:1.67%
controls:0.69%
cases:0.78%
controls:0.19%
—
—
—
—
—
—
cases:0.70%
controls:0.16%
cases:1.43%
controls:0.27%
15
62
883
8910
7
17
891
8955
—
—
—
6
14
857
8684
11
21
759
7623
Inpatient Hospital
21 [8717]
7.0e-02
4.5e-02
8.3e-03
—
1.2e+00
4.6e-01
8.6e-02
cases:34.86%
controls:33.28%
cases:10.58%
controls:10.16%
cases:1.22%
controls:1.21%
—
—
cases:2.78%
controls:0.86%
cases:13.67%
controls:9.13%
cases:30.39%
controls:28.60%
313
2986
585
5986
95
912
803
8060
11
109
887
8863
—
25
77
873
8884
118
794
745
7904
234
2186
536
5458
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.2e-01
1.7e-01
1.1e-01
—
6.2e-01
6.2e-01
5.9e-01
cases:14.37%
controls:9.95%
cases:6.01%
controls:5.10%
cases:0.89%
controls:0.80%
—
—
cases:1.45%
controls:0.78%
cases:8.57%
controls:4.81%
cases:20.26%
controls:12.38%
129
893
769
8079
54
458
844
8514
8
72
890
8900
—
13
70
885
8891
74
418
789
8280
156
946
614
6698
ispaghula (psylla seeds); oral
A06AC01 [21600555]
6.8e-01
7.4e-01
—
—
—
3.1e-02
9.4e-01
cases:3.90%
controls:2.01%
cases:1.89%
controls:0.91%
—
—
—
—
—
—
cases:1.04%
controls:1.01%
cases:5.58%
controls:2.26%
35
180
863
8792
17
82
881
8890
—
—
—
9
88
854
8610
43
173
727
7471
Dysphagia
R13 [45573013]
1.2e+00
—
—
—
—
—
1.6e+00
cases:1.11%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.37%
10
29
888
8943
—
—
—
—
—
14
28
756
7616
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
1.6e+00
—
—
—
—
—
1.1e+00
cases:1.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.34%
9
18
889
8954
—
—
—
—
—
8
26
762
7618
Pain general/multiple sites
A01 [2002000142]
8.9e-02
1.6e+00
—
—
—
1.3e+00
8.7e-01
cases:0.78%
controls:0.71%
cases:0.89%
controls:0.18%
—
—
—
—
—
—
cases:0.81%
controls:0.23%
cases:1.82%
controls:0.77%
7
64
891
8908
8
16
890
8956
—
—
—
7
20
856
8678
14
59
756
7585
Nose symptom/complaint other
R08 [2002000889]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.29%
—
—
—
—
—
—
11
22
759
7622
Extraction of root of tooth
EBA30 [2001301929]
1.1e+00
-1.0e+50
—
—
—
—
1.6e+00
cases:0.56%
controls:0.19%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.21%
5
17
893
8955
0
7
898
8965
—
—
—
—
8
16
762
7628
orphenadrine, combinations
M03BC51 [21604113]
6.0e-01
6.7e-01
—
—
—
9.9e-01
3.7e-01
cases:5.68%
controls:3.21%
cases:1.89%
controls:0.98%
—
—
—
—
—
—
cases:2.09%
controls:0.78%
cases:4.94%
controls:3.47%
51
288
847
8684
17
88
881
8884
—
—
—
18
68
845
8630
38
265
732
7379
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
2.6e-01
—
—
—
—
1.6e+00
7.1e-01
cases:1.22%
controls:0.95%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.26%
cases:1.69%
controls:0.84%
11
85
887
8887
—
—
—
—
11
23
852
8675
13
64
757
7580
Back syndrome with radiating pain
L86 [2002000705]
8.8e-01
—
—
—
—
—
1.6e+00
cases:0.78%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.35%
7
29
891
8943
—
—
—
—
—
13
27
757
7617
One hour or less
ZXE00 [2001311394]
-2.0e-02
3.0e-01
—
—
—
8.2e-01
7.5e-01
cases:5.68%
controls:5.78%
cases:1.89%
controls:1.40%
—
—
—
—
—
—
cases:2.78%
controls:1.24%
cases:8.18%
controls:4.04%
51
519
847
8453
17
126
881
8846
—
—
—
24
108
839
8590
63
309
707
7335
Sedation and analgesia
WX002 [2001310758]
3.9e-01
—
—
—
—
1.6e+00
6.7e-01
cases:1.78%
controls:1.21%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.22%
cases:1.82%
controls:0.94%
16
109
882
8863
—
—
—
—
9
19
854
8679
14
72
756
7572
liraglutide; parenteral
A10BJ02 [1123630]
1.1e+00
1.4e+00
—
—
—
1.4e+00
1.6e+00
cases:0.89%
controls:0.31%
cases:0.89%
controls:0.21%
—
—
—
—
—
—
cases:0.93%
controls:0.23%
cases:2.47%
controls:0.52%
8
28
890
8944
8
19
890
8953
—
—
—
8
20
855
8678
19
40
751
7604
Rheumatism, unspecified
M79.0 [45567658]
1.6e+00
—
—
—
—
2.0e+00
1.6e+00
cases:0.89%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.43%
controls:0.30%
8
17
890
8955
—
—
—
—
5
7
858
8691
11
23
759
7621
ibuprofen
R02AX02 [1588667]
4.1e-01
3.2e-01
5.2e-01
—
4.0e-01
4.6e-01
3.6e-01
cases:45.21%
controls:35.37%
cases:21.38%
controls:16.47%
cases:3.45%
controls:2.07%
—
—
cases:3.12%
controls:2.12%
cases:24.68%
controls:17.11%
cases:49.61%
controls:40.65%
406
3173
492
5799
192
1478
706
7494
31
186
867
8786
—
28
190
870
8771
213
1488
650
7210
382
3107
388
4537
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
4.1e-01
3.2e-01
5.2e-01
—
4.0e-01
4.6e-01
3.6e-01
cases:45.21%
controls:35.37%
cases:21.38%
controls:16.47%
cases:3.45%
controls:2.07%
—
—
cases:3.12%
controls:2.12%
cases:24.68%
controls:17.11%
cases:49.61%
controls:40.65%
406
3173
492
5799
192
1478
706
7494
31
186
867
8786
—
28
190
870
8771
213
1488
650
7210
382
3107
388
4537
Assessment of need for aid
SPAT1229 [2001700330]
7.8e-01
—
—
—
—
—
1.6e+00
cases:0.56%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.25%
5
23
893
8949
—
—
—
—
—
9
19
761
7625
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
—
—
—
—
—
1.6e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.17%
cases:1.17%
controls:0.25%
—
—
—
—
—
7
15
856
8683
9
19
761
7625
hydrocortisone
S02BA01 [21605166]
3.8e-01
4.5e-01
7.8e-01
—
1.6e+00
9.5e-01
6.1e-01
cases:9.24%
controls:6.53%
cases:3.79%
controls:2.45%
cases:0.56%
controls:0.26%
—
—
cases:0.89%
controls:0.19%
cases:4.63%
controls:1.85%
cases:10.39%
controls:5.94%
83
586
815
8386
34
220
864
8752
5
23
893
8949
—
8
17
890
8944
40
161
823
8537
80
454
690
7190
CBC panel - Blood by Automated count
58410-2 [40761511]
1.2e-01
4.5e-01
7.1e-01
—
4.2e-01
3.9e-01
2.2e-01
cases:29.62%
controls:27.23%
cases:22.94%
controls:15.99%
cases:5.68%
controls:2.86%
—
—
cases:3.56%
controls:2.38%
cases:21.78%
controls:15.83%
cases:39.22%
controls:34.13%
266
2443
632
6529
206
1435
692
7537
51
257
847
8715
—
32
213
866
8748
188
1377
675
7321
302
2609
468
5035
Excessive and frequent menstruation with irregular cycle
N92.1 [45539073]
4.2e-01
1.2e+00
—
1.0e+50
—
1.5e+00
5.5e-01
cases:1.45%
controls:0.96%
cases:1.22%
controls:0.36%
—
—
cases:1.00%
controls:0.00%
—
—
cases:1.39%
controls:0.31%
cases:2.21%
controls:1.28%
13
86
885
8886
11
32
887
8940
—
9
0
889
8972
—
12
27
851
8671
17
98
753
7546
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
—
—
—
—
—
1.6e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.20%
cases:1.17%
controls:0.26%
—
—
—
—
—
8
17
855
8681
9
20
761
7624
Seborrhoeic keratosis
L82 [45548208]
3.4e-01
1.5e+00
—
1.0e+50
—
4.9e-01
9.9e-02
cases:1.11%
controls:0.79%
cases:1.34%
controls:0.30%
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.58%
controls:0.36%
cases:1.43%
controls:1.30%
10
71
888
8901
12
27
886
8945
—
5
0
893
8972
—
5
31
858
8667
11
99
759
7545
Other bipolar affective disorders
F31.8 [45586237]
1.5e+00
1.2e+00
1.4e+00
—
1.4e+00
1.1e+00
1.3e+00
cases:1.34%
controls:0.30%
cases:0.78%
controls:0.23%
cases:0.56%
controls:0.13%
—
—
cases:0.56%
controls:0.13%
cases:0.93%
controls:0.30%
cases:1.30%
controls:0.35%
12
27
886
8945
7
21
891
8951
5
12
893
8960
—
5
12
893
8949
8
26
855
8672
10
27
760
7617
risperidone; oral, parenteral
N05AX08 [21604559]
1.5e+00
1.3e+00
—
—
—
9.9e-01
9.8e-01
cases:3.12%
controls:0.71%
cases:1.22%
controls:0.35%
—
—
—
—
—
—
cases:1.04%
controls:0.39%
cases:1.69%
controls:0.64%
28
64
870
8908
11
31
887
8941
—
—
—
9
34
854
8664
13
49
757
7595
Menstruation irregular/frequent
X07 [2002001292]
1.4e+00
1.8e+00
—
—
—
—
1.5e+00
cases:1.00%
controls:0.25%
cases:0.67%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.35%
9
22
889
8950
6
10
892
8962
—
—
—
—
12
27
758
7617
Gas panel - Capillary blood
24337-8 [3022313]
1.5e+00
—
—
—
—
—
—
cases:1.22%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
11
25
887
8947
—
—
—
—
—
—
hydrocortisone and antiinfectives
S03CA04 [21605208]
7.4e-01
7.7e-01
—
—
—
9.5e-02
7.5e-01
cases:3.67%
controls:1.79%
cases:1.34%
controls:0.62%
—
—
—
—
—
—
cases:0.70%
controls:0.63%
cases:4.16%
controls:2.01%
33
161
865
8811
12
56
886
8916
—
—
—
6
55
857
8643
32
154
738
7490

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
360
187
30.56
307.65
1.8
1.5
1.55
3.49
nmol/l
4.76
327
172
279
85
46.24
307.65
1.4
1.1
7.12
6.42
umol/l
0.90
263
79
261
423
8.15
163.31
1.5
1.4
9.28
10.87
u/l
1.11
225
346
287
906
4.12
80.29
2.1
2.0
366.71
384.73
nmol/l
0.73
262
849
257
776
4.18
76.06
1.7
1.6
308.52
303.58
mu/l
0.12
249
692
128
244
5.91
65.63
1.9
1.5
427.25
364.94
mu/l
0.73
106
198
53
40
13.98
56.61
2.3
1.4
82.72
93.16
nmol/24h
0.32
53
40
267
1058
3.13
49.78
1.5
1.4
12.64
22.09
iu/l
8.53
231
908
118
293
4.46
44.00
1.5
1.4
9.75
20.92
u/l
5.31
98
248
47
44
11.19
43.81
1.4
1.2
—
—
—
0
0
47
52
9.46
38.90
1.9
1.8
1.36
6.03
nmol/l
0.57
39
38
122
365
3.69
34.96
1.6
1.5
0.34
0.50
nmol/l
0.88
104
311
47
68
7.22
31.19
1.2
1.4
380.29
449.43
mu/l
0.42
47
68
47
70
7.01
30.38
1.2
1.4
72.51
75.90
%
0.81
47
70
479
3027
2.19
30.09
2.3
1.8
98.25
98.37
pmol/l
0.02
265
1693
55
100
5.78
29.26
2.6
1.6
38.55
20.43
ng/l
0.92
55
100
306
1665
2.24
27.42
4.9
4.1
8.30
9.46
mg/mmol
0.18
204
1028
302
1644
2.23
26.95
3.9
3.5
38.82
52.67
mg/l
0.64
202
1050
357
2122
2.10
25.09
4.0
3.3
8.17
7.79
mmol/l
0.67
312
1867
450
2921
2.04
24.77
4.1
4.1
36.91
37.23
g/l
0.70
423
2768
484
3242
2.01
24.21
6.5
5.4
1.22
1.22
mmol/l
0.86
425
2784
38
59
6.67
23.60
1.2
1.4
—
—
—
0
0
323
1885
2.09
23.54
1.8
1.5
20.51
20.49
nmol/l
0.01
287
1693
437
2855
1.99
23.14
5.6
5.0
1.22
1.22
mmol/l
0.46
404
2648
848
7148
2.89
22.10
7.2
4.5
38.85
36.74
mmol/mol
8.83
817
6865
726
5740
2.16
21.61
7.4
6.7
74.83
72.43
u/l
1.35
699
5455
905
7946
4.63
21.52
15.3
10.5
139.53
139.55
mmol/l
0.13
894
7769
904
7971
4.41
20.49
15.6
10.6
3.92
3.89
mmol/l
4.15
892
7769
250
1388
2.09
20.36
1.8
1.6
447.93
38712731.00
pmol/l
2.05
220
1227
32
22
15.01
19.50
1.2
1.1
—
—
—
0
0
866
7526
2.89
18.47
5.6
3.8
5.90
5.56
mmol/l
10.39
826
7134
516
3758
1.83
17.93
4.7
5.2
8.62
9.52
umol/l
2.86
489
3559
844
7274
2.56
17.75
6.6
4.9
14.43
14.28
pmol/l
1.24
803
6888
568
4288
1.82
17.23
4.6
4.1
6.56
6.18
mmol/l
3.63
537
3852
352
2328
1.82
16.42
2.8
2.4
49.67
59.10
u/l
2.87
331
2170
169
873
2.14
16.29
1.7
1.6
1079.19
1161.48
nmol/l
0.67
138
675
517
3868
1.75
15.46
3.1
2.4
70.32
74.19
nmol/l
2.60
485
3655
899
8126
3.38
14.85
8.1
5.7
1.67
1.72
mu/l
0.89
871
7816
329
2184
1.78
14.83
2.3
2.1
2.66
2.49
mg/l
0.81
293
1893
299
1956
1.77
14.02
3.8
3.4
7.40
7.40
ph
0.18
217
1364
363
2514
1.72
13.88
2.7
2.9
2.35
2.35
mmol/l
0.27
338
2350
332
2246
1.74
13.80
2.8
2.6
26.04
25.34
ng/l
0.02
143
987
265
1688
1.79
13.52
2.4
2.2
319.50
296.57
umol/l
3.64
234
1539
139
713
2.11
13.51
5.2
5.1
1.04
1.05
mmol/l
0.30
130
653
400
2876
1.68
13.11
3.4
2.9
27.02
26.37
u/l
0.28
379
2741
178
1014
1.93
12.88
2.6
3.1
0.84
0.82
mmol/l
0.46
167
967
92
418
2.33
12.00
1.3
1.3
4.39
3.19
ug/l
2.06
85
392
288
1937
1.70
11.88
3.4
2.5
—
0.80
—
0
5
296
2019
1.68
11.52
1.9
1.8
0.93
0.81
mg/l
0.18
218
1514
174
1024
1.86
11.29
3.1
2.9
5.57
4.60
e9/l
0.29
149
936
607
4967
1.63
11.11
3.4
2.9
—
0.20
—
0
5
194
1187
1.80
11.08
2.2
2.7
400.44
511.68
ng/l
0.58
152
952
355
2557
1.62
11.06
8.9
6.8
1.12
1.07
inr
1.39
293
2108
155
892
1.88
10.76
1.7
1.5
—
—
—
0
0
550
4425
1.58
10.54
6.5
6.0
0.18
0.17
e9/l
0.32
499
3967
918
8616
3.68
9.92
17.6
12.2
66.90
65.61
umol/l
0.80
910
8520
274
1898
1.63
9.77
2.3
2.0
224.90
157.51
u/l
0.25
262
1813
819
7350
1.88
9.69
4.4
3.3
1.41
1.17
mmol/l
15.01
775
7023
868
7955
2.17
9.54
5.7
4.2
2.79
2.83
mmol/l
0.69
827
7645
527
4256
1.54
9.49
6.2
5.7
0.55
0.52
e9/l
3.35
478
3768
168
1028
1.77
9.49
2.6
2.2
2.53
2.47
g/l
0.82
147
943
180
1133
1.73
9.19
2.7
2.3
14.92
14.70
umol/l
0.13
165
1054
31
91
3.49
9.11
1.3
1.5
361.15
469.84
pmol/l
0.54
26
76
916
8623
3.34
9.09
12.6
9.3
27.35
23.20
u/l
13.88
902
8433
525
4262
1.52
9.04
6.3
5.7
0.04
0.04
e9/l
0.55
474
3766
276
1959
1.58
8.73
1.4
1.3
12.49
26.27
iu/ml
4.34
57
562
407
3159
1.51
8.50
1.9
1.8
1.54
1.29
mmol/l
6.03
352
2820
859
7901
2.00
8.41
5.2
3.9
4.62
4.77
mmol/l
5.22
829
7623
102
554
1.94
8.37
3.4
3.0
7.35
7.34
ph
0.36
77
396
534
4391
1.50
8.37
6.3
5.7
2.14
1.98
e9/l
3.46
494
3982
341
2558
1.52
8.33
6.3
5.8
—
—
—
0
0
164
1032
1.71
8.33
1.2
1.3
116.18
165.03
u/ml
1.06
65
410
149
920
1.74
8.09
2.8
2.3
25.39
23.91
%
0.61
133
851
357
2717
1.51
8.09
1.4
1.3
1.31
1.84
u/ml
0.36
103
760
482
3916
1.47
7.79
6.5
5.8
7.85
8.12
%
1.83
456
3700
147
917
1.71
7.68
2.0
1.8
—
—
—
0
0
854
7882
1.90
7.64
5.1
3.9
1.36
1.54
mmol/l
37.37
817
7571
698
6134
1.53
7.46
3.9
2.9
36.43
30.83
u/l
3.19
672
5919
479
3910
1.46
7.42
6.4
5.7
2.49
2.68
%
1.71
453
3687
41
161
2.62
7.35
1.1
1.1
1.58
3277.88
iu/ml
0.51
13
39
461
3744
1.45
7.29
10.7
9.1
0.00
0.00
e9/l
0.14
396
3078
477
3910
1.45
7.12
6.6
5.7
0.62
0.68
%
1.60
448
3677
488
4018
1.45
7.10
6.3
5.5
57.22
56.48
%
0.86
467
3861
46
197
2.40
6.90
3.7
3.4
—
—
—
0
0
887
8338
2.11
6.83
15.0
11.0
16.48
18.77
mg/l
1.96
770
6680
106
1706
0.57
6.79
1.5
1.6
773.07
996.29
mu/l
2.14
84
1453
218
1543
1.54
6.76
2.4
2.4
9.42
10.23
e6/l
0.21
203
1400
194
1338
1.57
6.75
2.5
2.5
505.02
517.41
mosm/kgh2o
0.32
180
1185
491
4074
1.43
6.70
6.4
5.6
29.62
29.85
%
0.22
471
3897
133
838
1.68
6.67
2.2
2.5
4.98
5.50
umol/l
0.27
104
710
185
1267
1.57
6.63
2.3
2.1
2.44
2.41
mmol/l
1.77
164
1131
122
753
1.71
6.60
3.2
3.4
4.56
4.61
pmol/l
0.25
106
682
267
1984
1.48
6.53
3.5
2.6
0.25
0.34
e6/l
0.40
211
1391
555
4737
1.42
6.29
9.2
8.3
4.36
3.94
e9/l
5.35
497
4190
60
300
2.07
6.23
3.5
2.9
7.42
7.42
ph
0.28
47
250
18
36
5.08
6.20
2.8
3.2
—
—
—
0
0
27
93
2.96
6.20
2.0
2.4
89.73
115.95
ug/min
0.17
16
64
302
2318
1.45
6.19
3.4
2.8
59.87
46.28
e6/l
0.20
244
1699
172
1176
1.57
6.18
2.5
2.2
7086.93
6500.95
u/l
0.06
46
511
297
2279
1.44
6.08
1.5
1.4
2.16
2.08
g/l
0.42
182
1499
11
12
9.26
5.79
1.0
1.1
15.64
82.27
pmol/l
1.15
11
12
89
522
1.78
5.76
3.2
2.7
1.86
1.74
%
0.51
76
469
151
1030
1.56
5.46
1.2
1.2
—
—
—
0
0
240
1801
1.45
5.45
1.4
1.3
2.86
9.71
u/ml
3.84
87
754
192
1384
1.49
5.35
1.4
1.4
582.07
530.95
titre
0.08
29
296
301
2369
1.40
5.20
5.7
5.5
—
—
—
0
0
77
448
1.78
5.13
4.6
3.7
91.24
69.49
ng/l
1.12
69
406
28
110
2.59
5.08
6.3
7.0
429.83
385.06
umol/l
0.32
23
99
64
353
1.87
5.07
4.2
2.5
77.30
73.70
e9/l
0.33
54
241
668
5990
1.40
5.05
5.1
4.1
—
2.82
—
0
8
36
160
2.30
5.04
1.3
3.4
1.04
0.94
nmol/l
0.28
29
135
203
1497
1.45
5.02
2.3
2.4
99.98
89.06
ug/g
0.19
153
1159
23
84
2.78
4.80
1.1
1.3
0.14
0.39
nmol/l
0.53
13
59
104
670
1.62
4.78
5.4
6.1
104.70
104.89
mmol/l
0.21
104
670
198
1469
1.44
4.72
4.1
3.6
—
—
—
0
0
131
894
1.54
4.71
1.2
1.2
—
—
—
0
0
911
8768
2.22
4.66
14.6
10.0
—
—
—
0
0
645
5790
1.36
4.56
5.3
4.1
640.67
1886.00
e6/l
—
6
65
313
2523
1.36
4.56
2.8
2.4
—
—
—
0
0
83
512
1.68
4.52
8.3
7.5
7.42
7.41
ph
0.74
51
282
610
5443
1.34
4.40
4.0
3.3
74.06
60.17
ug/l
1.27
587
5205
78
477
1.69
4.39
1.1
1.1
—
—
—
0
0
160
1166
1.45
4.17
3.5
2.3
0.97
1.49
e6/l
0.49
97
545
359
2991
1.32
4.09
4.4
3.3
69.23
62.16
e6/l
0.09
268
1881
54
305
1.82
4.01
2.4
2.1
—
—
—
0
0
43
226
1.95
3.98
6.3
5.3
—
—
—
0
0
74
459
1.66
3.97
3.6
3.1
—
—
—
0
0
21
83
2.57
3.82
1.2
1.3
—
—
—
0
0
148
1081
1.44
3.81
3.4
2.4
4.82
4.92
e6/l
0.04
85
466
68
418
1.68
3.79
1.5
1.4
0.25
0.24
mg/l
0.03
22
161
78
499
1.61
3.72
4.0
3.3
7.38
7.38
ph
0.34
45
275
128
914
1.46
3.71
1.5
1.3
—
—
—
0
0
36
183
2.01
3.67
7.7
4.8
0.77
0.90
%
1.35
36
174
43
753
0.55
3.67
1.6
1.5
—
—
—
0
0
106
733
1.50
3.60
2.3
2.3
31.48
39.16
u/l
1.12
85
602
45
773
0.56
3.59
1.6
1.6
—
—
—
0
0
38
199
1.95
3.58
7.9
4.6
1.97
1.61
%
0.97
38
191
78
506
1.59
3.53
8.6
7.5
0.78
0.68
mmol/l
0.09
62
412
43
742
0.56
3.49
1.6
1.5
1.26
1.25
mm
0.04
27
546
45
252
1.83
3.47
1.1
1.2
—
—
—
0
0
77
501
1.58
3.44
3.6
2.8
1.23
1.23
mmol/l
0.06
66
428
28
133
2.14
3.42
3.8
2.0
8.39
6.27
pmol/l
0.74
28
133
151
1131
1.40
3.37
3.1
2.8
233.73
241.46
ng/l
0.01
71
561
62
964
0.62
3.37
1.5
1.6
55.14
58.88
ug/l
0.21
49
819
96
662
1.50
3.32
1.3
1.2
—
—
—
0
0
397
3427
1.27
3.27
2.2
1.9
—
—
—
0
0
66
420
1.61
3.24
1.8
1.6
9.41
8.80
u/ml
0.08
15
110
531
4757
1.27
3.18
4.3
3.5
0.00
0.01
estimate
0.80
112
995
109
780
1.45
3.14
2.1
1.9
0.00
0.04
estimate
1.05
24
187
529
4742
1.26
3.13
4.2
3.4
0.00
5.78
estimate
1.34
120
1023
524
4695
1.26
3.10
4.2
3.4
0.00
0.00
estimate
0.50
121
1018
432
3789
1.26
3.05
3.8
3.0
6.23
6.24
ph
0.11
253
2217
215
2630
0.76
3.02
1.8
1.8
—
—
—
0
0
933
9187
2.83
2.95
24.7
17.3
277.12
268.08
e9/l
4.61
926
9061
12
37
3.27
2.94
2.2
2.3
16.42
15.82
umol/l
0.07
12
37
60
383
1.61
2.93
2.0
2.0
0.27
0.01
estimate
0.89
22
148
30
157
1.94
2.88
2.9
2.4
2.27
1.42
index
0.38
15
74
17
71
2.42
2.81
1.3
1.1
101.94
114.17
pmol/l
0.50
17
71
38
218
1.77
2.76
3.9
2.9
368.64
348.13
mg/l
0.05
11
82
113
834
1.40
2.76
1.3
1.3
—
—
—
0
0
112
827
1.40
2.73
2.0
1.8
—
—
—
0
0
84
588
1.47
2.73
1.3
1.2
—
—
—
0
0
933
9194
2.74
2.69
24.8
17.4
7.26
6.72
e9/l
16.07
925
9050
933
9192
2.77
2.68
24.7
17.3
4.58
4.46
e12/l
15.45
925
9055
12
43
2.81
2.65
1.1
1.5
142.17
150.13
mmol/24h
0.14
12
43
16
67
2.41
2.64
1.0
1.7
—
—
—
0
0
7
15
4.69
2.60
1.3
1.4
62.86
64.73
ug/l
—
7
15
72
496
1.49
2.54
1.8
2.4
0.17
0.31
e6/l
0.69
66
469
87
623
1.44
2.53
1.3
1.3
—
—
—
0
0
71
489
1.49
2.51
3.9
3.4
1.93
1.67
mmol/l
0.27
63
416
136
1052
1.34
2.50
1.2
1.2
—
—
—
0
0
63
424
1.52
2.49
9.4
8.1
125.35
120.05
g/l
1.32
63
418
11
38
2.92
2.42
1.5
1.7
—
2384.00
—
0
5
5
8
6.28
2.37
1.4
1.0
134.76
105.86
mu/l
—
5
8
12
46
2.63
2.36
1.1
2.2
2.67
2.00
u/field
—
6
29
21
106
2.00
2.27
3.5
4.6
52.60
133.53
u/ml
—
7
34
408
3639
1.21
2.26
3.7
3.2
0.07
0.03
estimate
0.57
94
846
67
468
1.46
2.24
2.4
4.1
18.80
17.61
ug/l
0.03
44
343
28
158
1.80
2.19
1.2
1.2
—
—
—
0
0
41
258
1.62
2.18
9.7
8.3
16.96
15.94
%
2.12
41
247
44
284
1.58
2.12
1.3
1.2
—
—
—
0
0
22
116
1.92
2.12
2.8
2.3
2.53
2.29
mmol/l
0.17
14
67
19
95
2.02
2.11
12.4
7.0
11.74
10.87
mmol/l
0.37
19
90
8
25
3.22
2.10
4.0
3.8
0.50
0.68
index
—
8
25
5
10
5.02
2.07
1.0
1.5
2.20
4.30
ug/l
—
5
10
19
96
2.00
2.06
12.4
6.9
105.53
105.14
mmol/l
0.12
19
91
95
1238
0.74
2.06
1.3
1.3
—
—
—
0
0
29
170
1.73
2.02
1.2
1.5
18.92
34.41
nmol/l
3.15
24
154
85
634
1.37
2.00
2.0
2.7
9.56
10.36
g/l
2.12
74
594
218
1848
1.23
1.95
3.6
3.4
99.04
98.10
%
0.25
208
1797
12
51
2.37
1.95
1.5
2.1
—
—
—
0
0
22
120
1.85
1.94
3.3
2.1
—
—
—
0
0
18
93
1.95
1.86
1.8
1.5
—
—
—
0
0
318
2826
1.19
1.73
3.2
2.8
0.01
0.08
estimate
0.57
99
851
82
624
1.34
1.72
4.8
4.3
0.22
0.79
%
2.55
23
140
96
749
1.31
1.71
1.4
1.3
186.55
304.09
u/ml
0.36
89
700
17
89
1.93
1.70
1.3
1.2
—
—
—
0
0
182
1537
1.23
1.69
1.7
1.6
—
—
—
0
0
308
2738
1.19
1.66
2.3
2.0
—
—
—
0
0
84
647
1.33
1.64
5.2
4.7
0.00
0.13
%
1.42
23
121
85
657
1.32
1.62
2.2
2.3
16.07
21.13
au/ml
—
8
82
42
287
1.49
1.62
3.4
2.5
57.05
96.02
ng/l
1.43
37
256
46
321
1.46
1.60
1.4
1.3
55.61
133.21
pmol/l
1.26
46
311
38
255
1.51
1.60
2.1
2.4
0.63
0.62
%
0.02
38
255
10
43
2.34
1.59
2.4
2.0
3.86
3.88
mmol/l
—
10
43
10
43
2.34
1.59
2.4
2.0
102.20
106.21
mmol/l
—
10
43
170
1437
1.22
1.57
2.1
2.1
—
—
—
0
0
48
340
1.43
1.56
2.0
2.2
—
—
—
0
0
82
635
1.32
1.55
5.2
4.5
0.00
0.09
%
2.62
22
129
7
27
2.60
1.51
1.4
1.1
211.89
87.08
nmol/l
—
7
21
34
226
1.52
1.51
6.9
6.5
—
—
—
0
0
42
292
1.46
1.51
1.5
2.0
6.63
4.49
ug/l
0.29
31
257
299
3320
0.85
1.46
1.7
1.8
—
—
—
0
0
9
38
2.38
1.46
1.8
1.8
124.44
135.50
nmol/l
—
9
38
21
125
1.70
1.44
2.0
2.3
—
—
—
0
0
30
196
1.55
1.44
1.2
1.4
—
—
—
0
0
6
22
2.74
1.43
1.0
1.7
17.52
15.76
%
—
6
22
281
2507
1.17
1.43
4.3
3.5
0.00
0.00
estimate
1.08
114
989
60
450
1.36
1.42
1.1
1.2
—
—
—
0
0
161
1881
0.83
1.42
1.5
1.6
—
—
—
0
0
64
485
1.34
1.42
1.8
1.9
1.44
1.28
g/l
0.19
57
457
30
197
1.54
1.41
3.3
3.1
25.56
25.16
mmol/l
0.30
30
187
57
425
1.36
1.40
8.9
8.0
—
—
—
0
0
17
96
1.79
1.39
1.1
1.2
—
—
—
0
0
35
239
1.48
1.39
1.2
1.4
410.00
437.45
mg/l
0.20
35
226
9
41
2.21
1.37
2.6
1.9
1.18
1.19
mmol/l
—
9
41
16
90
1.79
1.33
1.8
2.3
—
—
—
0
0
6
24
2.51
1.30
1.3
1.8
8.95
7.80
mmol/l
—
6
24
17
99
1.73
1.27
1.0
1.1
4.90
7.02
iu/ml
—
5
30
449
4178
1.14
1.26
2.9
2.7
—
—
estimate
—
0
0
82
656
1.27
1.26
5.2
4.4
0.45
0.95
%
0.77
22
151
47
347
1.37
1.25
1.6
2.4
20.03
20.19
s
0.13
38
303
32
220
1.47
1.25
1.5
1.4
273.33
333.58
ug/g
0.85
21
115
31
212
1.48
1.24
1.2
1.3
24.86
23.59
e6/l
0.02
21
163
15
85
1.78
1.23
1.5
2.0
9.29
52.52
u/ml
0.49
15
85
33
230
1.45
1.21
1.5
1.3
—
—
—
0
0
87
705
1.26
1.21
1.7
1.9
—
—
—
0
0
31
215
1.46
1.17
1.2
1.4
15.96
1306.28
e6/l
0.56
25
172
5
20
2.51
1.15
1.0
1.3
6.68
5.50
mmol/l
—
5
20
256
2307
1.15
1.13
4.2
3.9
—
—
—
0
0
46
346
1.35
1.11
1.7
2.2
2.47
4.16
iu/l
1.86
23
165
92
759
1.24
1.11
1.7
1.9
—
—
—
0
0
92
1106
0.81
1.10
1.5
1.5
3.48
3.37
mmol/l
0.43
58
716
229
2053
1.15
1.08
4.5
3.3
—
0.14
—
0
7
13
74
1.77
1.07
1.1
1.0
—
—
—
0
0
92
764
1.23
1.05
1.7
1.9
—
—
—
0
0
232
2087
1.15
1.05
3.7
3.3
1.02
2.48
kg/l
0.80
141
1383
11
60
1.84
1.03
1.0
1.1
1502.36
1407.18
miu/ml
0.10
11
60
11
60
1.84
1.03
1.1
1.3
57.55
66.88
umol/l
1.57
11
60
40
299
1.35
1.02
1.0
1.1
1.35
0.70
u/ml
0.21
14
123
47
361
1.32
1.01
1.9
1.7
—
—
—
0
0
26
181
1.45
0.99
1.2
1.2
—
—
—
0
0
7
36
1.95
0.97
1.6
1.7
0.43
0.00
estimate
—
7
36
7
36
1.95
0.97
1.0
1.4
27.14
40.92
mmol/l
—
7
36
26
182
1.44
0.97
1.2
1.4
1.43
4.20
u/ml
—
7
71
6
27
2.23
0.93
1.2
1.3
—
—
—
0
0
92
776
1.21
0.92
2.2
2.1
6.13
6.21
ph
0.35
59
500
90
758
1.21
0.91
1.7
1.9
—
—
—
0
0
27
193
1.41
0.91
1.3
1.1
—
—
—
0
0
21
143
1.48
0.90
3.6
3.5
4.16
4.02
e9/l
0.16
21
143
5
103
0.48
0.89
1.2
1.4
—
—
—
0
0
5
103
0.48
0.89
1.2
1.4
—
—
—
0
0
45
352
1.29
0.87
1.1
1.1
4.98
2.83
u/ml
0.33
25
178
89
754
1.20
0.86
1.6
1.9
—
—
—
0
0
12
72
1.68
0.85
1.3
1.5
1.82
1.83
mmol/l
0.03
12
65
16
104
1.55
0.85
1.5
1.8
—
—
—
0
0
6
31
1.94
0.84
1.0
1.1
14.67
39.48
iu/ml
—
6
31
17
250
0.67
0.84
1.2
1.1
—
—
—
0
0
17
250
0.67
0.84
1.2
1.1
—
—
—
0
0
46
364
1.28
0.83
3.1
2.4
1.02
1.02
ratio
1.39
41
327
52
418
1.26
0.82
1.3
1.3
0.24
1.47
u/ml
—
5
29
124
1410
0.86
0.82
1.6
1.7
3.56
3.25
ratio
1.98
88
1005
11
65
1.70
0.82
1.1
1.2
—
1.80
u/ml
—
0
5
67
557
1.22
0.79
1.5
1.4
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
38
296
1.30
0.78
1.2
1.3
36.00
10.50
u/ml
—
6
54
271
2919
0.90
0.77
1.8
1.8
—
—
—
0
0
40
503
0.79
0.76
1.1
1.1
1.58
1.59
g/l
0.11
40
503
11
67
1.65
0.75
1.7
1.7
93.17
91.68
%
0.88
11
67
40
317
1.27
0.73
1.0
1.1
4.61
4.43
u/ml
0.04
19
169
41
510
0.79
0.72
1.1
1.1
0.86
0.86
g/l
0.07
41
510
11
68
1.62
0.72
1.3
1.5
4.51
6.11
ug/l
1.76
11
56
7
40
1.76
0.71
3.6
2.6
35.43
54.53
umol/l
—
7
34
35
274
1.29
0.70
1.7
2.2
—
—
—
0
0
25
187
1.35
0.68
1.5
1.4
—
—
—
0
0
7
42
1.67
0.68
3.3
1.9
579.00
79.74
nmol/l
—
7
42
112
992
1.15
0.66
1.3
1.5
—
—
—
0
0
34
269
1.27
0.64
1.1
1.1
1.96
4.96
u/ml
1.34
16
127
50
415
1.22
0.63
1.6
2.2
8.23
8.67
iu/ml
0.03
12
95
14
96
1.47
0.61
1.2
1.3
—
—
—
0
0
102
904
1.14
0.61
1.5
1.3
—
—
—
0
0
327
3454
0.92
0.60
2.3
2.2
—
—
—
0
0
29
228
1.28
0.59
1.2
1.3
—
771.43
—
0
7
41
337
1.23
0.58
1.1
1.1
7.52
5.07
eliau/ml
—
6
55
38
311
1.23
0.56
1.1
1.3
—
—
—
0
0
23
177
1.31
0.55
1.6
1.4
120.00
163.47
au/ml
—
7
48
89
791
1.14
0.53
4.0
3.3
—
—
—
0
0
20
153
1.31
0.50
1.1
1.1
—
—
—
0
0
10
67
1.50
0.50
1.1
1.1
—
—
—
0
0
14
101
1.39
0.49
1.1
1.2
13.70
13.27
u/ml
—
5
50
29
235
1.24
0.48
1.0
1.0
0.01
0.09
u/ml
—
7
68
395
3791
1.07
0.48
2.8
2.4
—
—
—
0
0
36
300
1.21
0.47
1.1
1.1
1.04
1.77
u/ml
0.65
20
145
7
48
1.46
0.47
1.1
1.2
—
—
—
0
0
43
367
1.18
0.44
1.8
2.3
3.51
4.61
umol/l
0.98
29
281
7
51
1.38
0.44
3.3
2.9
—
—
—
0
0
26
211
1.24
0.44
1.2
1.3
209.43
238.24
u/ml
0.30
14
139
30
248
1.22
0.43
1.0
1.1
2.81
5.87
u/ml
0.91
13
106
16
122
1.32
0.42
4.2
2.7
—
—
—
0
0
5
32
1.57
0.42
1.4
1.1
—
—
—
0
0
8
58
1.38
0.41
4.1
3.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
69
616
1.13
0.41
1.1
1.1
—
123.93
—
0
14
19
152
1.26
0.37
1.1
1.1
—
—
—
0
0
18
143
1.26
0.37
3.6
3.5
25.13
22.21
mg/l
—
8
96
58
517
1.13
0.36
1.1
1.1
—
—
—
0
0
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
26
217
1.20
0.36
1.0
1.1
25.94
15.40
au/ml
—
10
68
5
79
0.63
0.35
1.4
3.3
—
—
—
0
0
6
42
1.43
0.35
1.0
1.7
—
—
—
0
0
6
43
1.40
0.35
1.3
2.5
1208.00
1924.93
mg
—
6
43
6
46
1.31
0.33
2.7
2.6
—
—
—
0
0
7
54
1.30
0.30
3.3
2.9
640.29
511.18
e6/l
—
7
45
7
55
1.27
0.30
3.9
2.8
254.29
224.02
e6/l
—
7
48
8
62
1.29
0.28
1.1
9.0
9.89
6.42
mmol/l
—
8
48
8
62
1.29
0.28
8.4
1.8
34.00
31.89
pg
—
8
62
12
149
0.80
0.26
1.1
1.4
—
—
—
0
0
14
114
1.23
0.25
1.1
1.3
—
—
—
0
0
16
134
1.20
0.23
2.2
2.1
—
—
—
0
0
7
92
0.76
0.22
1.3
1.4
—
—
—
0
0
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
5
42
1.19
0.21
1.2
1.1
105.02
160.17
iu/ml
—
5
42
0
10
0.00
0.21
0.0
1.0
—
9.80
—
0
5
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
1.19
—
0
13
23
202
1.14
0.20
1.2
1.2
—
—
—
0
0
69
647
1.07
0.19
1.2
1.4
215.75
236.86
miu/ml
0.19
36
331
29
322
0.90
0.19
1.8
1.9
—
—
—
0
0
6
53
1.13
0.18
2.7
2.5
—
—
—
0
0
22
194
1.14
0.18
3.5
3.1
60.64
58.09
%
0.61
22
194
5
67
0.74
0.17
1.2
1.0
—
—
—
0
0
86
821
1.05
0.15
2.0
1.7
—
—
—
0
0
26
285
0.91
0.14
1.2
1.1
—
—
—
0
0
10
85
1.18
0.12
1.2
1.1
—
—
—
0
0
11
95
1.16
0.11
2.1
1.6
0.55
0.49
e9/l
0.29
11
95
15
166
0.90
0.10
2.4
2.7
—
17.76
—
0
5
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
11
98
1.12
0.07
1.2
1.1
—
—
—
0
0
9
87
1.03
0.07
1.2
1.1
—
—
—
0
0
8
92
0.87
0.06
1.0
1.3
—
—
—
0
0
8
93
0.86
0.06
1.3
1.4
2.62
2.95
g/l
—
8
66
8
93
0.86
0.06
1.3
1.4
0.22
0.35
g/l
—
8
68
8
93
0.86
0.06
1.3
1.4
4.96
6.13
g/l
—
8
68
29
299
0.97
0.02
1.4
1.3
—
—
—
0
0
12
123
0.98
0.00
1.1
1.1
—
—
—
0
0
21
211
1.00
0.00
1.2
1.0
6.19
2.50
eliau/ml
0.82
12
111
0
5
0.00
0.00
0.0
1.6
—
302.20
—
0
5
0
5
0.00
0.00
0.0
1.0
—
189.80
—
0
5
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
262.00
—
0
5
0
5
0.00
0.00
0.0
2.8
—
3.52
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
0.13
—
0
7
0
6
0.00
-0.00
0.0
11.3
—
0.33
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
3.02
—
0
6
0
7
0.00
-0.00
0.0
2.0
—
241.71
—
0
7
7
69
1.01
-0.00
3.4
2.8
1675.00
1324.08
e6/l
—
7
62
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
67
0.89
-0.00
1.3
1.1
13.17
7.45
mm/h
—
6
67
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
66.38
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_HYPERTRICHOSIS – Hypertrichosis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).